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The disease lathyrism has been known.for a long time. Its occur"."' 
ence has been recorded in a number of countries in Europe, Africa and 
Asia. It -is a neurological disorder resulting in_spastic paralysis.of 
the legs. Periodic surveys since 1833 have revealed that this disorder 
is due to the.- consumption of L. sativus seeds (1). It was found that 
the toxic components were in the alcohol soluble.fraction of L. sativus 
seeds. Subsequent analysis. of· alcohol extract_s of the L. sati"lros. seed 
meal revealed the presence of ,.two new ninhydrin-positive compounds. One 
was.characterized as L-homoarginine (2), the other compound as 8-,-N-
- . 
oxalyl-1-:-a, B--diaminopropionic acid (3)... However, L. satfvus seeds were 
of1;:en contaminated with vicia seeds and .it was prqposed that the latter 
might. be the actual toxic component (1)... Ressler (4) subsequently iso-
lated B-cyanoalc;i.nine from v;Lcia seeds, which was found .to exert neuro-,-
toxic effects in rats. 
In 1962, Bell (5, 6) presented preliminary results of .a systematic 
investigation of the acidified 50% ethanol-soluble, ninhyd·rfn ... positive 
materials in.49 speciefi) of lathyrus peas, He identified a,Y-diamino-
butyric acid (DBA) as one·of,the unknowns.and showed that the.three 
lathyrus species associated with human lathyrism contained homoarginine 
but•no DBA. A compound designated as lathyrine has been chara.cteri.zed 
1 
2 
as a-(2"'-amino".'"pyridine-4-yl)-alanine, which is a "cyclic-type" deriva-
tive of h9moarginine (7). B-4,minopr.opionitrile has been identified as a 
toxic principle of.lathyrus related peas responsible for osteolathyrism 
and aminoacetonitrile and 6-,,mercapt~ethylamine produ.ce a similar toxic-
ity (8, 9). 
The·L-isomer of DBA appears to be.neurotic .in rats and mice al-
thol,lgh it·may not be the neurotoxic .agent of human lathyrism (10~12). 
It is a component.of bactertal cell walls (13), of certain Lathyrus and 
related seeds (6, 10, 14-16), and of the polymyxin antibiotics elijbor-
ated by some of the Bacillus strains .(17). It ,ha$ peen found in .bovine 
brain (18); this·. is the .only species of mammals so f~r reported ·to. cort.-
tain this compound. 
At present, a.total of five polymyxins are known (19)~ Circulin 
(20), isolated· from Baci.llus .. circulans,. and .polypeptin (21; 22), iso-
lated from Bacillus kremieniewski, .also appear to pelong to the poly".'" 
myxin category. The polymyxins differ somewhat i.n pharmacolog·ii:::al prop-. 
erties but are similar in having a narrow ant.ibacteria1 spectrum that is 
limited to ce~tain gram negative ·pacteria, .including .Hemophilis ~influ-
enza, Brucella abortus, Salmonella· .enteritidis,. .Escherichia-· coli, and -- ~ ·. ' . --
Protel,ls vulgaris (23). 
Thepolymyxins are related chemically. They are strongly basic, 
cyclic polypeptides, and yield DBA, threonine, and .isopelargonfc acid, 
a branched chain, saturated, optically active fatty .acid .(6-methyl-octan-
1-oic) upon acidic ,hydrolysis. Most of the DBA residues .in polymyxin 
have free y-amino groups; most are of the L-configuration (24, 25). 
As,mentioned previously, the free amino acid L-DBAis neurotoJ$:iC in 
rats an~.mice. A dose of 680 mg per kilo body weight injectE?-d intraper-
itoneally caused hyperirritability, ,tremors, conv'l,llsions and death (14, 
26). The symptoms of toxicity were.different and occurred much more. 
slowly subs.equent ,to .L-.DB,A .treatment .than .did those.:.:cesult;ing from la-
th.al· doses ef otper amino .acids .o.r .annnonia (26) •. 
A rather striking · observ.ation was .made ·by Christensen--.and his· 
associates cm the concentration .of the homologous a.~w .... diamino acids 
within l;Lving cells .. (27) •. Wherel!ls .e-,aminoalanin~ .aq.c;J: DBA ·were very 
readily concentrated ·by free .... living cells, ornithine and lys·ine were 
concentrated to a much smaller .extent. Indeed,. tlJ,e .concentration of 
DBA,occurs a.t·so rapid a rate,as·to.be frequently fatal to'the.cells. 
It ·is possi,ble that the abrupt .change in .transfer facility"in passing 
3 
from the lower members of . this .series . to . th,e higher can ·.be· :explained ·on. 
steric grounds; f:he · two lower .members .a:ce capaple '.Qi ,.fo:tttj.ns ~stable five 
or six membered rings involving the two am;Lno groups and a metal ·ion 
(27 1 28). Albert: (~9) has shown,th,at the copper salts of,these two di-
amino acids involve mainly both .amino .gi;.oups and,. .to a :smaller extent, 
the a..-amino with the :carb(?:gyL.group, .. whereas .the_.copper salts of orn::J.-




/c-· o"'- + 
CH -(CH ) -CH · C:u l2 23 ~~ N+ . 
3 
s .... Amino~latline 
DBA 
Th.e finding that addition .of pyridoxal accelerated .the accumula-
tion of amino acids by.ascites cells suggested that the transfer reac-
tion involves not.only chelation with metals but also the formation, at 
the same time, ofa.stable Schiff 1;,asewith pyridoxal (27). It is pos-
sible that the Schiff base of DBA is chelated to both nitrogen atoms 
(28): 
The metal-pyridoxal-amino ?cid complexes had been .prepared by 
Christensen. and Co.llins as crystals (30).. .The molar .ratio .of .metal 
4 
pyridoxal : DBA depends .on the metal .and pH, as .1:.1:.1,. .1:.2:l .or .l:2:2. 
These chemical and steric characteristics are .very import:ant. ·· They may 
account, in part, for the physiological.differences between DBA and its 
longer carbon .chain analogs, ornithine and lysine •. The findings of 
Christensen and Riggs (27) on 1;:he accumulation of amino acids, including 
the homologous a,w-diamino .acids, within free-,living cells··agree with 
this proposal. 
. Biosynthesis of, L-DBA 
In tq.e studies of tc;,xic components of Lathyrus pe~s; Ress.ler's 
group encountered 13-cyanoalanine as an intermediate in• .the .conversion of 
asparagine ·· to DBA (10). Instead of finding 13-cyanoalanine as a natural-. 
ly occurring neurolathrogen ·in L.: latifolius, .they isolated .and identi-
fied L-DBA as a component toxic to rats, ,which might be considered as a 
5 
reduction product of S-cyanoalanine (14), During .the .assimilation of 
H14cN by the seedlings of Cicia sativa, Tschiersch (31) found that 
S-cyanoalanine and asparagine were the first compounds to be labelled, 
1-DBA and an unidentified compound were also highly labelled. This re-:-
sult agrees with the findings of Ressler et al. In 1966, Ressler and 
Nigram (32) were able to demonstrate that DBA could be synthesized from 
both homoserine and aspartic acid in the seedlings of L •. sylvestris W, 
and suggested that the pathways for the formation of homoserine and DBA 




~ . i • Th . . "'~ Homosen.ne~. reon1.ne 
However, a new enzyme, 8-"cyanoalanine synthase, has been isolated and 
purified from acetone powders of etiolated .seedlings of blue lupine by 
Hendrickson (33), and Blumenthal et al. (34) reported that this enzyme 
catalyzed the'reaction 
Cysteine + HCN-----6-cyanoalanine + H2s . 
Probably 8-cyanoalanine is hydrolyzed to asparagine but the .reverse 
reaction does. not occur (34). During the assimilation of H14cN by the 
seedlings of blue lupine, sorghum, and common vetch, Blumenthal~ al. 
(34) demonstrated that L-cysteine-3-14c was the source of 3 carbon atoms 
of asparagine while Hl4cN was converted into the amide carbon of aspara-
gine without separation of the C. and N atoms of the cyanide group, L-
cysteine-3-14c is a more efficient precursor of the carbon atoms of as-
paragine in the three species studied than is L-serine-1-14c (34). 
Fowden and Bell (35) observed that 8-cyanolanine coulc:'l be converted to 
y-glutmyl-8-cyanoalanine in V. sativa by the action of a.transpeptidase. 
6 
Blumenthal .et al. (34). .reported :that .asparagine .did .not .appear. to be. -- ' . 
converted· to (3-cyanoalanine, .and .that .a .cyanogenic glucoside would con-. 
stit~te an alternate-source of HCN and.perhaps the only source of carbon 
for the nitrile group of, (3-cyanoalanine. Tschiersch (36). has de1I1.onstrat-
ed that phenylalanine-z-14C fed .to ·.v •.. ari.gustifola seedl:1,ngs. formeq (3-,cy-
anoalanine labelled predominantly in the nitrile carbon.·_ Tyrosine; val-
ine, and isoleucine as well as phenylalanine are known precursors of 
cyanoge~ic glucosides (37). 
Chemical Synthesis of DBA 
DBA has .been.synthesized chemically. The .earliest preparation was 
made, through t_he malonic condensation reaction with :bromoe thy.lphthali-
mide, by Fischer (38) ip. 1901. · In a series of .studies on the optical 
configuration of-. the amino acids, Karrer, Escher, and Widmer (39) pre· 
pared L-Dl3A by the Hofmann degradation of acetyl-L-glutamine .in .a yield 
of 18%. - DBA obtained by both methods .was isolated :as the .crystalline 
oxalate. -· In 1939, Adamson. (40), making use of the .Schmidt .r,eaction, 
treated L-glutamic acid witJ sodium azide in H2so4 .. solution and isolated 
DBA as the crystallin,e dipicrate (mp 178 ... 180°) .in a yield of 42%. By 
using ion-exc;:hange techniques (41), the free amino acid hydrochloride 
salt can.be obtained. 
The methods described above, and many others, .for .the .p.r:eparations 
of DBA are of interest but .of little pract;ical value .in preparing large 
amounts of,the compo~nd. One of the best available procedures .f<;,r this 
purpose is that of Carter, Van .Abee le, and Rothrock (42L which also has 
the virtue of being a general method for the synthesis of ~,y-diamino 
acids. Reaction of diazomethane with ethyl aci::ylate leads to ·pyrazoline 
which, on catalytic hydrogenation in the presence of ,Raney Nickel at 




The mammalian metabolism of D'."" and L-DBA was f:trst·. investigated by 
Mushahwar and· Koeppe (41). They observed that a considerable amount· .. of 
radioactiv:(.ty f+om each·isomet of DBA-2 .... 14c was excre~ed in the.urine by 
rats, the L-,isomer was. more readily converted to respiratory co2, and a 
major urinarycatabolite of each isomer was a-alanine-l-;-14c (41). Al-
though the finding of a-alanine-1-14c suggests removal of the a-amino 
group and subsequent oxidative decarboxylatiol)., the labeling patterns 
obtained in tissue glutamate .(41) suggest that some .gamma deaminatio11 
and o:xidation occµrs with the formation of oxal.acetate or a .related com-· 
·· pound. Thus, the .metaboliem oLDBA apparently proceeds via. transamina-
tion and,/or oxidation of. th~ .a ... amino group, with .subseque11t decarboxyla ... 
tion. This metabolic route is common to most,amino acids •. :The metabo-
lis.m and metabolites~ es1>ecially the catabolic. rate, may. be of., value in 
elucidating the tox:(.c mechanisms.of this amino acid.· 
Transamination 
Nonertzymic. transamination was first demonstrated '.by Herbst and 
Engel (43) in 1934. Pyruvic- acid was boiled with 0-aminophenyl .acetate· 
in.aqueous solutio11. The mechanism.proposed .involved ,tautomerization of 
the Schiff's base. Suc}:l Schiff's bases have been crystallized .by.Witkop 
and Beiler (44). Nonenzymic transamination was found to .ta~e .place 
between a wide variety of,amino and,keto acids whell these.are heated to-, 
·gether on paper (45). Similar reactions.occur in aqueous.solution at 
room, temperature, near neu~rality, when the keto acid is replaced by 
8 
. glyoxylate (46-4B). 
Although enzymic. transarilination was reported o·riginally ·as a gener-
al reaction, subsequent studies (49-52) i,ndicated. that· enzymi,c transc.:m-
ination may be limited to reactions between.alanine, glutamate, aspar-
tate .· and their. a.-keto analogs~ About, 1950, when reactan~s of higher 
purity and improved analytical procedures permitted. more. ac·cura te. deter-
minations of reaction products, practically all of the naturally occur-
ring a-amino acids were shown, to· undergo· tra~sa.mination reactions (53), 
Transamination plays a general r.ole,.in amino acid metabQlismo: Although 
the number of transa.minases in any given .. tissue is unknown, ·the sc.op1;: 
of enzymic transamination is·indicated by the·fa:ct that almos~ every 
amino acid tq.at occurs naturally ·.can be shown. to .undergo trans·a.mtnation 
with o~e · or another keto ac::id in crude extracts· (53). 
Based. on the above ·knowledge .of t:ta-q.s.amina.tion, it· seems l;i.kely 
that both nonenzymic and enzymic transam:i,.nation reactions should· be con-
sidered for the case of DBA. · The .dialyzed crude extracts., should be. of 
interest. Pyruvate, o~a.lacetatei · and a,..,-ketoglutarate ·mfght ·serve as 
amino group. acceptors. 
A variety of.analytical methods suitable for estimating trans,-
aminase activity have appeared .in recent literature~.· .. Among these, the 
spectrophotometric meth.od ··is· the most convenient (54-58). However, it 
is limited· to a· transamination ·.system .in wq.ich .one of· the, components, 
either added as.substrate·or fo:i::med as a·reaction product, has a meq.s-
urable characteristic absorptioI,1.·at a sqitable.wave length. This method 
is suitable for the tra"Q,sam:i,.nat:ton .system, ·of oxalacetic·acid 'and either 
DBA or glutamic acid, the rat:e of .disappea,ranc~'·or formation of. .oxalace-
tate · being me~sured at 280 mµ. 
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Oxidative Deamina tion . 
The flavoprotein enzymes·. thEit catalyze· the oxidation ·of amino acic;is 
to .. the corresponding a.;..keto a<::,ids and ammonia have been 'known for many 
years.. In ·1935, -'Bernhiiim et al. (58) reported that<re·sting cells of· 
Ba'cillus proteus catalyzed the. oxidation of certain amino acids. In th.e · 
same year Krebs published·his classical.paper·ort· the·oxidation of the· 
L"'."'. and. D-isomers of. amino acids by homogenates of· mai;nmalian liver and 
kidney (59). The ovet.,..all reaction catalyzed by· the flavoprotei11 amino ·_ 
acid oxidases may be represented as shown in Eq •. L · Reactions 2-4 rep-
resent the classical'int:erpretation .of the reactions catalyzed by amino 
acid oxidases; .. reaction 1 is the sum of these. three reactioi\s · (59"'."'61): · 
RCH(NH+)COO- +·E(FAD) ~RC(.;,NH)C007 + E(F<Al)lt) +:H+ .:_ __ (2) 3 · .. · 2' · - · 2 
The· hydrogen -peroxide .·. formed' may react no1;1.enzymically with . the d-ke to 
acid product (Eq. 5). When catalase is prese:p.t; ·reaction 5 .does not 
:> RCOO + CO 2 + H2 0 -----~----.,----,--- ( 5) 
take place, .and only one atom of.oxygen-is.taken up. per mole·of.amino 
acid oxidizeq: 
RCH(NH:{>coo- + ~02~RCOCOO- + NH4+ ---- ------ -, ... ·· - (6) 
In·the absence 'of.catalase, the.over":'all reaction _is as.depicted-in Eqo 
7. (59): 
RGH(NH3+)coo"'" + Oz~ RCOO- + NH4+ + COz ___ "." ___ '.'c ... -'":--- (!) 
Optical specificity is a striking feature· of .the L-amino ac:)'..d 
oxidase of snake venom and D-amino acid .oxidase of mammalian kidney. 
Both act on a wide variety of amino _acid substrates, and -- although both 
contain FAD as the prosthetic group, they exhibit -- absolute specificity 
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for one optical isomer of. the substrate .. in the oxidative deamination of 
amino acids, as well as in.the synthesis of amino acids from a-'-keto 
acids and ammonia. The strict antipodal specificity may be ascribed to 
specific structural features of the enzyme, probably including the 
nature of the binding of the flavin to the. protein (59). 
Problems relating to the metabolic and physiological significance 
of the amino acid oxidases have been considered (60, 62, 63). In the 
case of D- or L-'-DBA, the amino acid o}!:idases of rat kidney. may play an 
important role; Although the activities are low when compared with the, 
L-amino acdd. ox.i.dase of snake venom, Koeppe and Mushahwai:' (41) were able 
to demonstrate 6-alanine as a .major. urinary catabolite .of .each .isomer. 
Ammonia Detoxification and Free Amino Acids in Brain 
The relatively high content of free amino acids in brain tissue 
have made them the. foe.al point ·of many biological studie.s (64"".'68), Most 
of these are non-essential amino acids; glutamic acid, glutamine, 
Y-aminob(ityric. acid (GABA), aspartic add and N,-,acetyl as.partic acid· 
making up 75 per cent of the, totaL Of these, N-acetylaspart:1..c acid and 
GABA appear to be peculiar to nervous tissue, 
In a study using several hypoglycemic agents, :Lnsuli.n was the only 
one which caused major changes in the levels of the amino acids of rat 
brain (69). Decreases in glutamine, GABA, glutamic acid and alanine; a 
large increase in aspartic acid content, and no change in the level of 
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N"'-'acetylaspartic.acid .in the brain .of insulin,-,treated rats were ob'r 
served. (69-73). · The effect .01f .insulin appeared to .be directly related 
· to blood sugar levels. When the level of insulin was not sufficient to 
reduce the blood sugar content to 25 mg per cent~ or when glucose was 
administrated· (to insulin treated i=l,nimals), no effect on· the brain. amino 
acid levels was observed (69, 70) •. O'Neal and. Ko.eppe .(74) showed that 
hypoglycemia produced by ligation of the hepatic artery .and portal vein, 
produced similar results. 
In an ammoniia toxicity study with rats, a 300 percent increi3,se in 
brain glutamine concentration was observed 15 minutes after a LD 99 • 9 
dose of ammonium acetate had been injected intraperitoneally (75). 
Berl et al. (76) observed that glutamine was the only cerebral component 
showing a considerable increase in concentration as a result of arrnnonia. 
infusion. This inc:i;-ease occurred without a.corresponding drop in.gluta,-
mic-acid concentration. From studies of the incorporation of radioac-:-
tivity from intravenouslyinjected gltitamic.acid-u-14c and gluta.mine';'" 
u-14c into the.amino acids of rat.and·mouse.brain,Laj.tha.et al. (77) 
demonstrated· that· there was, an exchange bet.wee11, blood'.and brain amino 
acids rather than a net uptake or uptake. followed by .utilization.. In· 
1953, Flock et al~ (78) observed a la·rge increase in the concentration 
of glutamine, without .a corresponding drop in. glutamic .acid .cm'i.tent, in 
the cerebrum of hepatectomized dogs. · Since this in0.rease in glutainine 
was not proportional to the increase in plasma glutamiri.e, .it was thought 
. ' 
to result from the brain detoxification of ammonia by .de.nova .synthesis --- . ' 
of glutamine. 
The detoxification .of ammonia via.the hepatic Krebs"""Henseleit urea 
cycle· has been demonstrated by Greensteii:i et aL (79, · 80), who reported 
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tl'tatL--ornithirie, 1.:..citru:t.line and L...,arginine protecl;: aga;i..nst the am,... 
monia rele1:lsed from the 'injected ami.nci acids (81). ,The studies of Herr-
mann et al. (82) showed• that L-DBA could competitively inhibit the pud,-
fied ornithine carbamyl transferase .obtairled from Neurospora crassa. If 
'tnese were true in rats. intoxicated with L-DBA, L-arginine or 1.:..ornithine 
might enhance. detoxification. 
A Proposed Mechanism of Convulsion. 
An impairment in the biosynthesis.of GABA is apparent'in a number 
of convulsive states (83); the .. administration .of_ large doses .of GABA has 
adefinite anticonvulsive action (83). The need for such large doses is· 
attributed. to· the low permeability of the blood-brain. barrier. to a polar 
molecule like GABA. The 2-pyrrolidone has a stronger anticonvulsive 
action than GABA (84), apJlarently because it is a less polar molecule 
that penetrates the brain more easily where it is hydrolyzed to yield 
\ 
GABA (85). 
The main ccttabolic pathway of GABA is its.transamination with· 
~-ketoglutaric acid (85). It has been foundthat the inhibition of this 
reaction by hydroxylamine or aminooxyacetic acid produces an.increase.in 
GABA levels (86, 87) and counteracts the convulsive action of several 
agents, although the maximal anticonvulsive action does not coincide 
with the highest cerebral GABA (83). In 1967, Tapia et aL (88) ob-
served an.inhibition of glutamic decarboxylase activity, in both brain 
and liver, by L-glutamic acid-y-,hydrazide or aminooxyacetate at the onset 
of convulsions, in spite of the simultaneous increase in GABA levels. 
The results indicate that the inhibitio!). of glutamate decarboxylase ac-
tivity is.an important factor in the production of certain convulsions. 
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·simultaneous inhibition of GABA-a-ketoglutarate transaminase actiV'ity 
accounts for the increases in GABA concentration.. Tapia ~ aL (88) 
concluded that the convulsant effect of some substances could be due, in 
part, to the inhibition of glutamate decarboxylase activity independent 
of the total brain GABA concentration •.. 
Objectives of This Study 
Except for distribution and toxicity studies in mice (12, 89) and 
uptake studies with asc.ites tumor cells (27, 89, 90), the only investi-,. 
gations concerning the mammalian met.abolism, .of D- and L-DBA are those 
conducted by Mushahwar and Koeppe (41). More details remain to he elu-
cidated. The objectivesof this study were to attempt.to explain the. 
neurotoxicity of this component of certain Lathyrus peas and to eluci-
date its metabolism by amino acid oxidases and/or transaminases. Work. 
has involved the synthesis of possible metabolic intermediates, e.go, 
keto amino acids, the deter11i-ination of changes in certain brain amino 
acids in r~ts neurotoxic with DBA and the identification of products of 




Synthesis of a-Keto-y-'"Aminobuty:ric Acid (KABA) 
+ 
/J. 30 min 
Cone~ HCl 
b 2 hrs 
Preparation of ~-Alanine Ethyl Ester. S-Alanine (50 g) was sus-
pended in absolute ethanol (500 ml, U.S. Industrial Chemicals Co.), and 
dry HCl (Matheson Co.) was passed into the mixture until a clear solu-
tion was obtained. The solution was. heated for 30 minutes, concentra-
0 ted to dryness in vacuo (water pump, using a 30 water bath), and any 
excess HCl removed by reconcentration in vacuo after the.addition of 
absolute ethanol. The syrup obtained was dissolved in 200 ml of water 
and chilled in an ice-bath. Ice-cold 28% (100 ml, w/v) NaOH and then 
170 g of K2co3 were added over 40 minutes to the solution with stirring 
to salt out the amine, which was extracted several times with equal 
volumes of dry ether. Dry HCl was passed into the ether solution until 
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an aliquot dissolved.in 1 ml of water she.wed pH 3o5 (pH.paper), The 
precipitate was filtered off, wa:shed well with dry ether, and dried over 
P2o5 in vacuo overnight to give 74.4 g (87%). 
Preparation of·. 4--Carboethoxy-2, 3-Dioxopyrrolidine. The method· of 
Southwick et al. (91) with modification was used for preparation. To 
L 1 equivalents of sodium ethoxide (23, 4 g of sQdium metal) in 500 ml of 
absoluteethanol was added, overl5 minute~, with stirring, 425 ml of an 
absolute ethanol solution containing 72. 3 ml (c>ne equivalent) of· diethyl 
oxalate·and 74.4 g of 13-"alanine ethyl ester. The solution was stirred 
and heated under reflux for one ht. The yellow reactio~ mixture was 
cooled rapidly to room temperature ina c0ld water bath and poured, with 
stirring, into 2 liters of water at room .temperature. The mixture was 
acidified by addition of lOOmI of cone. HCl, cooled to o0 and stirred 
overnight at 4°, The precipitate which formed was. filtered· off, washed 
with 95% ethanol, .. and dri.ed for 2 hr.s by.<drawing air through the filter; 
then dried over P20,.. in .. vacuo·. .The yield waf3 42. 5 g (50%). :) -
After recrystali.zation from hot 95% ethanol, the 4-,carboethoxy-2 ,3-
dioxopyrrolidine gave white crystals and melted at 183-,187° with decom-. 
position (185-186°, decamp, , .. by Southwick et al. , .91) • The compound is 
soluble in hot water, hot 95% ethanol and acidic or alkaline solution, 
and insoluble in cold water arid c.old 95% ethanol, · The compr.;mnd gives a 
red color when treated with. 5% ferric chloride in 0.1 N HCl solution, a 
yellow precipitate with 2 ,.4-'dinitropheny:J_hydra.zine, and is· ninhydrin 
negative, 
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Preparation of KABA. Crude 4-carboethoxy-2,3....,dioxopyrrolidine 
(39.7 g) were added to 500 ml of cone. HCl and the sol1,1tion was flushed 
with nitrogen immediately to prevent oxidation and then heated at 95° 
for 12 hrs unc;ler a blanket of nitrogen. Thehydrolysate was cooled to 
room temperature in. an ice-bath,. concentrated to dryness i;n vacuo, and 
any residual hydrochloric acid was removed by a second concentration 
in vacuo at room temperature aft;er the addition of a.small amount of 
ethanol. A syrup was obtained. 
Preparation of 2 ,4-:Dinitrophenylhydrazone Derivative ,of KABA. The 
KABA.sample was converted (92) to the 2,4-di:p.itrophenylhydrazone deriva-
tive for purification. Assuming the yield of previous .. step to be,70%, 
an equivalent.amount of 2,4-dinitrophenylhydrazine was dissolved in 
sufficient 2 N HCl to ma~e a· 1% solution. The syrµp o~ ,KABA was dis-
solved in a small volume of water and added to the 2, 4-dini trophenylhy-
drazine solution. The mixture was st;irred for 7 hrs, filtered arid· the 
precipitate wa,s washed with· 2 N HCl and then with water. : The filtrate 
and washi~s were concentrated to a small·vol,ume to give an.additional 
10% of the derivative •. The .. 2,.4--dinitrophenylhydrazone·of KABA-(36.2 g, 
.52%) was recrystalized from 0.06 N HCl in methanol. 
Liberation of KABA. A 1 ·.g sample of KABA .2,.4~di:ti.it:cophenylhydra-
zone was dissolved in 300 ml .of 2 N HCl at 90° and O .AA :ml .o.f· .arii.salde-
hyde was added. The mixture·was stirred at 90-95°.for 5 min,·r..ooled 
to 15° in ice-bath, and filtered. The filtrate was heated.to 80° with 
1 g of decol9rizing charcoal (Darco G.;.60) as rapidly as possible with 
\ 
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stirring on the hot plate, cooled in an .ice-,bat.h and .filtered and the. 
filtrate.was then lyophilized to give light yellow crystalso These were 
washed with absolute ethanol, dried and found to melt at 130~140° with 
decomposition. The yield was 302 mg (66%). An additional 69 mg (15%) 
was obtained from the washings. 
The crystalline synthetic KABA is very hygroscopic, very soluble 
in water, and only slightly soluble in ether and absolute ethanoL It 
gives a yellow color with ninhydrin, an amber color with 5% FeC1 3 in 
Ool N HCl solution, and yellow .precipitate with 2,4.,.,di1iitroph,,::nylhydra-
zine i11 2 N .HCl solution .(rap 215-221 °, decomp • .). This, keto, acid, and 
its 2,4-dinit:cophenylhydrazone,.melt,with decomposi.tion, over a :wide tem-
peratl,rre r,:l.ngeo 
Synthesis of D-,a9y-Dia.minobutyric Acid 
D-a, y-Diaminobutyric acid (D-.DBA) was synthesized by .the .Schmidt 
degradation of D-glutamic acid according to the method of Adamson. (40) 
as modified by r<oe.ppe, Hill and Mushahwar (41, 93), without further ad-
dition of fuming H2so4 and NaN 3 o An amount of 200 mg of.D-:glutamic add 
was used in each reaction. After the reaction, the mixture was trans-
ferred to a beaker cooled in ice-bath and titrated to pH 6.5-7 .0 (pH 
meter) with hot saturated barium hydroxide solutiono The precipitated 
barium sulfate was removed by centrifugation! .The' .volurp.e of supernatant. 
solution was reduced in ~~ to about 50 ml and passed through a Dowex.,., 
1 x8 (acetate form, 100-200 mesh; 2. 4 x 30 c:m) column .and to.rough a 
Dowex,-1 x8 column (OH- form, 100-,200 mesh; 2. 4 x 35 cm). The colurnns 
were washed with 100 ml of water. It was assumed the unreacted p~glu-
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tamic acid and any excess so4 ___ .pre~ent in the _.solution ·were· removed by 
the acetate column. The OH-::- column was .washed with .an .additional 200 ml 
f fN + .. d -I+ A 1 d o water to remove any trace o ·. a an .Ba ions., D.;;;.DB was e ute 
from the OH column with 1 N HCl.. The fractions containing D-"DBA were 
combtned, the-volume was reduced to approximately :50 ml inthe rotatory. 
evaporator and the .concentrate was titrated to pH 3.5 to·4.0·with pyri-
dine. Ten volumes of absolute· ethanol were added· to·· precip·itate D-DBA 
as the monobydrochloride salt. The .precipitate.was filtered, recrystal-
lized from water-ethanol, washed with absolute ethanol, acetone and dry 
ether, and dried ove:i;: P 2o5 in vacuo~ The yield was 77%. It was·. homoge-
neous on paper chromatography in the solvent sys~ems· described by.Mush-
ahwar and Koeppe (41). It melted at.234-236° (decamp.) and showed 
23° 
[a] -23~3° · (c 1, 5 N HC!) as .determined with the polarimeter, .Wilkin-
D 
son (96) records mp 223-224° (decamp.) for D-form.monohydrochloride and 
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[oi.]D +23.8° for 1..:.form .. monohydrochloride (c L2, 6 B: .HC.l) .• · Fu e_t al. 
0 
(97) reported [a]25 -24.5° for D-form monohydrochloride (c 2%, 5 N 
D 
HCl). It gives a brown color with ninhydrin, and is soluble in water 
and insoluble in ethanol and ether. 
Preparatiqils ·.d-f ,. N,.;.,Triflucn::oacety:l. .~-:Bcrtyl, .Es:t.e::i:::s .and:N-.Ac.et:yl .. Ethyl Es-
ters of : Amino Adds .. . . . 
The amino acids or the mixture obtained from nonenzymic .transa-
mination.were.coriverted to N-:-trifluoroacetyl·n-butyl esters or N-acetyl 
ethyl esters~ which were separated by gas-liquid or thin-layer chroma-
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tography and analyzeq. by mass spectrometry. 
I 
Preparation of N....:.trifluor:oacetyl g-butyl Esters. The sample ob,... 
tained from nonenzymic .. transamination was evaporated to dryness. in vacuo 
after reduction with sodium b:o:rohyd-r·ide. Derivatives of .. this dried 
sample or of crystalline amino ac:ids·were. p:rep:a:red accor.d±n:g·.to Gehrke 
and Stalling (94). There are ·3 steps. About 60 mg of, amino acid was 
dissolved in 10 ml of L 25 N KC.l .(dry) in anhydrous methanoL The flask 
was stoppered and .the s,plution was st:i~ed for .30 minutes at 'room tern-
perature. · The excess methanoFand HCl wer~ ·remov:ed in the· rotary .evapor-
0 ator on a 40 water bath. The methyl es.ter hydrochloriq.es were trans,-
esterified with E_..,,.butanol. Ten m1·of :1..25 N HCl {dry) in .n-"bu;tanol were 
added. The, flask was, fitted with .;a CaSI:\ drying tube and placed in an 
oil bath maintained at ·100° by:a Multiple :Magnetic Rot F.late.S.tiqer. 
The solution was stirred for 2~ hrs. The·excess n""."butanol·and HCl were 
removed in. the r0tary evaporator 'on a. 40° water bath~ The a.cyla.tion of 
the n-butyl ester hydrochJ,.oride waei carried out at .room temperatureo 
The dried B,_-butyl ester.was· treated with 4 ml of methylene.chloride and 
1 ml of trifluoreac.etic anhydride;.. and stirred for 2 hrs. The solution 
was filtered thr:o:iiJ.gh.gla.ss wool, and·d:ded by a stream of nitrog~n gas. 
The·oil residue:was dissolved in0.3--,0.4 ml .of dry-ethyl ether. This 
sol1,1tion was, ready for gas,;.,liquid ··o.r thin-layer chromategraphy. and mass 
spectrometry. 
Preparation of . N..;Acetyl Ethyl Esters.· ·· The derivatives are· less 
volatile than those described above, but are usefuL The dried sample 
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of the reduced nonenzymic'tra:nsamination.mixture·or a.Illino acids was sus-
pended in 20 ml of absolute ethanol (for about.60 mg of amino acid) and 
dry Hct·gas was passed through .to dissolve all the residue. The solu-
tion was refluxed for 30 minutes at 90° and the excess.· ethanol and HCl 
were removed.by concentrating the solution to dryness :in·vacuo,·using a 
30° water bath. The gummy residue of ethyl ester hydrochloride was. 
treated with 2 ml of acetylchloride and stirred for Lhr. This reac-
tion was poor. Even.when triethylamine was·added, most of·the gummy 
residue did not dissolve.· The solution was. concentrated by a stream of 
nitrogen gas and on the. ste.am :plate. The oily residue was dissolved. in 
dry ethyl·ethe1:1prior.to analysis. 
·Results and 1):iscussions. 
4-Carboethoxy..,2 23-Dioxopyrrolidine 
Figure 1 shows.alternate reaction scheme13 for the formation of 
4...:.carboethoxy-2, 3-dioxopyrrolidine. It seems likely that a Claisen con"." 
densation followed by.lactam formation (steps 1 and 2 rather than 3 and 
4) may represent the principal reaction path~ 
The compound is hydrolyzed to KABA when heated under reflmc with 
cone. 'HCL Hydrolysis to· a-alanine occurs in alkaline .solution. 
KABA --· 
The synthesis of KABA is shown;in,Figure 2. 
The IR spectrutµ of .. our synthetic KABA is the same as. that of KABA 
• 
synthesi;ed by :t,1:acholan ~ al.. (Figure 3) · using a diUerent method 
(92, 95). 
KABA can be .. oxidatively decarboxy:J_ated to a-ala.nine by H202. at· any. 
C2H50'-c = 0 
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Figure:2~ The Synthesis of:a-Keto.,..Y-Aminobu,tyric Acid 
pH, and. reduced · to · a.+hydroxy-Y-aminobutyric acid .(HARA) .. (p.ur:p,le, color 
with ninhyrin) with sodium ·.bo.t:ohydride •. The reactions are shown in 
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· Figure 17. Both· a-keto and'.d"'-hydro:Jty-Y-aminobutyric ·acids· c:an·,.be iden-
tified by paper chromatography in several·solvent systems·(Table XII). 
Concerning·the Structure .of KABA 
The synthetic KABA contains no chloride ion after recrystallization 
from et:hanol-n2o. When its 2,4-dinitrophenyl}:lydrazc;me derivative was 
recrystalized from water·,,or ·washed well with cold 95% ethanol, or cold 
water, the IR spectra were modified (Figure. 4). 
KABA reacts rapidly with 2,4-dinit:rophenylhydrazine in 2 N HCl 
solution, suggesting that in 2 N HC:l solution substantial amounts of the · 
keto form exist. The NMR spectra of KABA dissolyed in n2o for 5 minutes 
and for 24 hours. (refrigerated) were: identical (Figure 5), exceJ)t, · for 
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the proton ratios given by NMR integration, these ratios were 3.85 : 
2 : 1.15 at 5 minutes; 4.12 : 2 : .0.88 at 24 hrs for .the three groups 
of peaks representing a total of 7 hydrogens. No enol hydrogen was ob-
served. Apparently, the enol hydrogen has been exchanged with deuter-
ium. 
The fact that KABA doei;; .not show a triplet at 3.0 PPM and that in-
tegration of the NMR spectrum of KABA shows a proton ratio of 2:1 at 3.0 
and 2.0 PPM, respectively, suggests the presence of.one vinyl and two 
methylene hydrogens besides HDO, and that KABA readily enolyzes in 
aqueous solution (Figure 5), Based on.the lack of chloride ion and the 
preference.of the enol form in aqueous solution, the structure of the 
KABA crystal is hypothesized to be a 6-membered cyclic internal salt. 
Probably, the compound is a cis or trans enol form in aqueous solution. 
The vinyl hydrogen may be locked so tightly that it cannot move freely. 
The structure of KABA would be represented as: 
+ H 00 
NH3GH2 " / 
\ OH C==C 
C=C/ t CH/ "C=O 
/ I 2 / 
H C=O 'NH O 
0/ 
+ 3 ..... 
(trans) (cis) 
N...:.Acetyl Ethyl Esters·· and N--Trifluoroacetyl n-Butyl Esters of. Amino 
Acids 
These derivatives were yellow or brown colored oils, soluble in 
chloroform and ether, insoluble in alcohol. The derivatives could be 
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separated by thin-layer chromatography and gas-liquid .chro.matography 
(GLC) on SE-30 cir OV-1 column. The results of the separation by GLC are 





Male albino rats,· obtained from the Holtzman Rat Co., Wisconsin, 
were given a commercial (Teklad Inc., Iowa) 25% protein rat diet and . . 
water ad l:i,bitum before the experiments. Leghorn cockerels, obtained 
from the Stillwater Hatchery were raised on.a commercial chick starter 
ration. Rats weighing 165-320 g and chicks weighing 190-250 g after a 
24 hr period of starvation (with water. ad libitum) were used. for all 
the·intraperitoneal treatment experiments. A group of rats were given 
200 µg of thyroxine (titrated to pH.9.0 with 0.1 N KOH) daily for 8 days 
before beginning the experiments. After the intraperitone?l admiri.istra-
tion of the test compounds dissolved in 2 ml of water, or an equal Yol-
ume of water for the control, the animals.were allowed to drink water 
ad libitum for the duration of.the experiment and given food 8 hrs after 
administration.· However, in three experiments.urine was collected over 
experimental periods.during which no water and food were provided for 
the rats. For the intracerebral treatment experiments.fed rats were 
used~ the test compounds were dissolved in 0.2-0.24 ml of wate-r or sa-
line (0.9% NaCl) and titrated.to pH 6.5-7.0. At,the termination of the 
experiment, the animals were decapitated, the desired tissues removed 
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and prepared for analysis. 
I$olation and Assay of Amino Acids 
Tissues .. to· be. analyzed for amino acids were blotted with filter 
paper and frozen in liquidnitrogen immediately afterdissection. Free 
glutamate, aspartate and glutamate from glutamine were isolated from the 
frozen tissue by.the method described by.Koeppe et.al. (74, 98), as 
s.hown in, the following scheme: 
FILTRATE 
+ Dowex.,.,l x8 Ac (1. 0 x 12 cm) 
H20 
NEUTRAL AND 
BASIC AMINO ACIDS 
J Hyro.lysis 3 N HCl 
Dowex-1 x.8 Ac-
lH20 
NEUTRAL AND · 
BASIC AMINO ACIDS 
0.5 N HAC· 
GLU ASP 
The brain was homogenized with 3.ml (per g tissue) of cold.0.6 N 
perchloric acid in a Potter-Elvenhjem homogenizer, centrifuged at 10.,000 
xg for 10 min and re".'"extracted with an amount of cold 0.33 N perchloric · 
acid equal to that of the.first supernatant solution.volume. The com"."" 
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'bined supernatant ·solutions were neutralize_d to .pH. 7.0 with 2 N KOH and· 
left in·. th.e refrigerator overnight ... to complete the precipitation .of the 
KC104• TheKC104 precipitate was,removed by centrifugation at 10,000 
xg for 10 minutes or filtration.·· The· liver and kidney ti.ssue were 
tre~ted ·the same .way except 5 ml instead of 3 'ml ,of perchloric: acid was 
used per g tissue.· 
' The· separation of glutamic .and. aspar1::ic ·, aciqs. was. acc·omplished · on 
a Dowex;,l · x8 · (Acetate. form, 100-200 mesh) column •... The neutralized ex-::-
tract wae passed over a .1. 0 x 12 cm collll;lln ·of, Dowex.-1 x8 acetate resin. 
at a flow rate of approximately 10 ml/hr. The column.was .washed with 
50 ml of distilled water, an~ the~ the.free glutamic.and aspattic acids 
were.eluted from the. column in t;hat order using 0 • .5 N acetic acid as 
described by Hirs, Moore, and Stein (99).. Collection of .2 .ml .fr.actions 
prove~ to be very satisfactory for the resolution of glutamic,.and as";" 
partic .acids. The amino acid containing fractions from these columns 
were. identified by spotting aliquots, on pH .7.4 .phosphate .. buffered filter · 
paper anq·developing with:ninhydrin. · The fractions containing glutamic, 
and a$partic acids were.pooled,and .diluted·to-50.ml and 25 ml,.:respec~ 
tively~ with.distilled water. 
The water effluent was made ·.3 N by the '9-ddition of. cone, HCl, and . 
autoclaved (15 lb/sq in) for 12 hrs. Th~ hydrochl,.oric .acid .was .. r.emoved 
by rotatory evaporaj:ion ,on a 50° water bath .in .vac1;1.o: (water pump). The, -· .· .. 
hydrolysates were taken up in 5 to lO·ml,of water, .neuti;;alized .wtth 0.5 
N potassium hydroxide, and passed. over. a Dowex-1 x8 acetate .coll,1mn as 
preyiously described. The-glut~mic ... acid.and aspar:tic acid .moieties of 
glutamine and asparagine were eluted from the •. column as. previously de-,. · 
scr:f,.bed. 
The,amount'of glutamate and aspa~tate eluted.from.the•column.was 
determined by the ninhydrin .method.of Rose1;1. (100) as modified by Grant 
(101) using glutamic and.aspa:rtic acids as standards. 
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The, free basic amino acids of brain, liver and kidney were isolated 
from percb,lorate. filtrates .of these .tissues on a ,column. (1.0 x 12· cm) of 
+ Amberlit~ CG-50 (Na form; 100-200 mesh). · Five volumes of 1.0 M acetate 
buffer• pH 4.7, per volume of resin were allowed to fl:ow through the 
col1,1mn at a rate; of o._5 ml/min; the column was next .rinsed free of ex-
cess buffer with water. A portion of the-neutral perchlorate.filtrate. 
was c;liluted·with water to 25 ml -and passed over the buffered Amberlite 
CG-50 column at appro~imately.0.5 ml/min •. The c;olumn was washed with 
water until (ninhydrin negative) the.acidic .an~ neutral amino acids had 
pasli;led through the column. The basic amino acids. were :then eluted with 
1.0 N HCl. To remove .ammonia-.from the eluates, t\}e :pH .. was .adjusted to 
11.5 with 2 N KOH and the .sol1,1tion was .. placed overnight in .an .ev:acuated 
desiccator containing 200 .ml .of cone. H2so4, .as.describe~ :by Moore,and 
Stein. (102). Th~·.sol1,1tio~ was. neutralized with .. 8Jlllll0nia-free· 1 ! HCl and 
the basic-ami.tio acids we-.;-e quantitatively determined .using L'":"'~BA hydro-
chloride as the standard (100,. ·.101); .. -A portion .of .tl;).e ,1sQlated .basic 
\ . -
amino acid.solu~ion was. desalted-by passage over .a.Dowex-,1 x8 (OH fo1'111; 
100-200 mesh) column (1 ... 0 -~ .12 .cm} .at .a rate .of about .20 .ml/lu:. The 
column was wash•d.slowly.with 100 ml-of water and.eluted with .o.s ! 
acetic acid. The acetic-.acid .was removed by evaporation -~·:dry,;1ess. 
The·free basic amino ac:l:ds were dissolved in water and .assayed.by as-. 
cending chrQmat;ography on Whatman.-No. 1. filter paper with .i~obilt:yt''~lco-
hol' me"!=hyl"'ethyl ketone -r ·water' aq. NH3 (,ep .• gr._().88)"*4:3;2':.1, by ... 
vol-.} .soi vent. (103). 
Assay of ··Total Brain Amino Acids b,y. Amino. Ac.id ... Analyzer 
The samples to be.analyzed by amino acid analyzer, Beckman Model. 
120C, were prepared according to.the instruction manual with modifica-
tion. 
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Brains obtained from treated rats were blotted with filter paper 
and.frozen in liquid nitrogen .immediately after dissection. Each brain, 
0.8:-1.2 g, was homogenized with 15 ml per.g tissue.of.cold 1% picric 
acid in a Potter-Elvenhjem homogenizer, for 20 seconds. The picric acid 
precipitat:e was removed promptly by centrifugation at 12,000 xg for 45 
minutes. The supernatant. solution was treated with approximately 20 g 
moist Dowex.,.2 x8, stirred for 30 minutes to remove.the excess picric 
acid, and filtered~ The resin was washed with five 4.,.mLportions of 
O. 02 N HCl. The filtrate and washings were combined and evaporated on 
a 28°-30° water bath in vacuo (water pump) to a .volume of about 1 ml. 
The contents were transferred with water into a .. 10 ml-beaker, .the total 
volume bein~ maintained at less than 5 ml. The pH .of the solution was. 
adjusted. to .6. 5 with 1 N NaOH,. then O .15 ml of freshly prepared O. 5 M 
Na2so3 solution was added. The pH of the mixture was adjusted within 
the range of 7.2 to 7.5, and the solution was exposed .to air for 4 hrs 
to convert both reduced and oxidized glutathiones to .glutathione-S':"'sul-
fonate. Both forms of glutathione interfere in this type:of chromatog-
raphy since they emerge (at,32°) as a very broad.peak underlying several 
amino acids from the aspartic acid· position to the praline· position. 
Glutathione-S-sulfonate emerges at the column volume, thus eliminating 
interference with other amirto acids or related compounds. 
The pH of the sample.was brought: to 2.0-2.2 with 1 N HCl, and the 
volume raised .. to 25 ml with 0.20 N sodium citrate buffer, pH 2.2. One 
33 
ml and two ml aliquots of sample were analyzed .on long and short columns, 
respectively, with an automatic recording amino acid aq.alyzer, Beckman 
Model.120C, as descr:i,bed by Spackman et al. (104). The neutral and 
acidic components were elutec;l and separated from each othe.r on the long 
column (52.3 x 0.9 cm) with 0.20 N sodium citrate buffer, pH 3.25, which· 
was changed to pH'4.25 ·after 155 minutes.. The temperature was set at 
32° and raised to 55° 100 minutes later.. The, basic amino acids remained 
on the long column; these .were assayed by a separate·run, using the· 
short column. The neutral and acidic components emerged from the sho:r:t· 
co],.umn .. (19. 3 x ·.O. 9 cm)· at column volume, while .the basics were eluted 
and separated from each other with 0.38 N sodium citrate buffer, .pH 4.26. 
The temperature initially 32°, was raised to. 55° after 185 minutes. The 
time required for the complete analysis is375minutes and .325 minutes 
for the. short and long .columns., respectively. Beckman Custom Spherical 
Resins were used: short.column, PA-,35 resin, 13 .µ si.ze with 7.5% cross-
linking; long column, PA-28 resin, 16 µ size witq. 7.5% cross-linking. 
The columns were equilibrated v7ith buffer. For, the quantitative deter,-
mination of amino acids the amino acid .analyzer was standarized with a 
mixture containing amino acids at known concent.rations. 
Determination of. Tissue .Ammonia and Urea and Blood .. Glucose 
Protein.free filtrates for ammonia analysis were prepared by pre-,. 
cipitation with 20% (blood) or 10% (brain) (w/v) .trichloroacetic acid 
according to.the methods of Nathan et al. (105) and Tews et al. (106). ---·- . -.- --.. 
For d~terminationof ammonia the microdiffusion method described by 
Seligson et al. (107) was combined with the nif1:hydrin colorimetry of 
Rosen (100) and Grant (101). Protein-free filtrates of blood, brain, 
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and liver.fo.r urea detennination.were .prepared.by.precipitation with 
Znso4 and Ba(OH)2' as described by .Somogyi .(108).~ Samples of. urine were 
preserved with toluene. The method of Archibald (109) .w.as adopted for 
the urea.quantitative ,assay method, in which urea reacted with a-isoni-
trosopropiophenone and measured at 540 mµ. The, procedure presented by 
Nelson anc;l Som<;>gyi (110, 111) was used.to determine the concentration 
of blood glucose.· 
TissueK+ and Na+ Analysis 
Liver, brain and kidney tissues obtained from L-'-DBA or.water 
treated-rats.were blotted, weighed and ashed at 550° in a muffle fur-
nace. The residue was dissolved in 3.6 N HCl and analyzed for K+ and 
Na+ with an atomic;! absorption spectrophotometer (112) by Mr. Thomas E. 
Nelson, Animal Science Department. 
Histopathological Examination of Tissue 
The brain, liver and .kidney obtained from L-DBA, .or water treated 
rats were blotted, cut into. 5-10 mm .. pieces and·· fixed .in 10% · (w/v) for-
malin. Sections 4-6 µ thick were prepared and stained with .haematoxy"'." 
lin-eosin for examination. The examination .was made by Dr. James B. 
Corcoran, of Veterinary Patho.logy Department. 
Incµbation and Analysis of Liver, Slices 
Liver slices (0. 5 mm thick) were prepared with a micro tone· (113). 
Slices of. approximately 0.5 g wet weight 'were incubated for 30 minut:es 
at 37° in 25.ml Erlenmeyer.flasks containing 4 ml of Krebs-R:i,nger bi,-
carbonate buffer, pH 7.4 (114). In some of the ,experiments liver slices 
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were incubated with L-:DBA, L-,ornithine, .. or L-,homoarginine during the 30 
minutes before the addition .of the ammonium chloride. Then 1 ml of 25 
mMNH4c1 was added and the .incubation continued for 1 hr (80). During 
the entire experiment,. the s.olutions were gassed with o2 + co2 (95:5). 
The addition of 0. 3 ml of ·3% (w/v) sodium lactate, pH 7.3,. to the incu-,-
bation medium (115), which enhanced the utilization of ammonia and pro-
duction of urea by the slices, was used in two of the later experiments. 
The,incubations were terminated by addition of 1 ml of 0.6 !!_ perchloric 
acid. Control flasks were prepared similarly except .that NH4 Cl was 
added after HC104• The mixtures were centrifuged at 15,000 xg for 15 
minutes; the clear supernatant$ were analyzed .for ammonia and urea. 
After diffusing for 3 hrs (107), the ammonia was quantitatively deter-· 
mined by Nesslerization (116). The iodinated Nessler's solution was 
prepared by dissolving 30 g of.KI, 41 g of HgI 2 and 2 g of r 2 in water 
and diluting to 200 ml with water. Urea was determined .by the method 
of·Archibald (109). 
Ornithine Transcarbamylase (EC .2 •. L.3 •. 3) Assay 
Rats fasted for 24 hrs were killed by decapitation, the liver was 
removed promptly and chilled in. ice.. A 1 g sample of liver was pas·sec! 
thrqugh a cold Harvard tissue press and homogenized with 19 ml of i~e-
cold water (117). The assay system of Brown and Cohen (118) was used 
to determine th<? enzymic activity in the water homogenate by measuring 
the rate of citrulline formation. The incubation mixture.consisted of 
L-ornithine, 20 µmoles; homogenate, 0.02 ml; glycylglycine buffer, pH 
8. 3, 90 µmoles; carbamyl phosphate, 20 µmoles; and L- or D-,DBA, 0-40 
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µmoles. The to ta! . volume was .made. up t<;> .2 .ml .by .the ;addition .of water. 
After preincubation for .10 .minutes~- ,the .reaction .was started by adding 
carbamyl phosphate; · and teri:ninated .by the .additior:i of .0,.6 .N .per.chloric 
acid. The con t:rols .we:r::e .similiir .except . that ca:rbamy.1: ·.phospl;ia. te was 
added after perchloric acid •. ,:. .The .precipitate ·.was remq.ved .by cent:rifuga-
tion, and the· clear supernatant .was .analyzed .fc;,r citrulline by the 
method of A:tch:i,bald ·. (119). as .modified by .Ratner. (120). 
· Materials 
L-a, y-diaminobutyric acid .monohydrochloride . (A-grade).;. L-:ho.moargin-
ine hyqrochloride (A .g_rade) ,- .L-,ornithine .hydrochloride :(A.grade}, L-glu.:. 
tatlline (A grade), glycylglycine (A.grade).a11d'dilithium carbamyl phos-:-, 
pha te. (B grade) were .obtained .from California .Corp •. for .Bioc"hl~inical Re-
search, Los Angles, Calif., _n...,_o.,.Y...,diantinobutyric ;acid ·:mondhyd:rocihloride 
was prepared by the Schmidt degradation.of D-.&lutamic .acid as·described 
in Chapter J:I. 
. Results 
Effecf of L.;.,a,Y..:,diaminobutyr:ic Acid·- (L-DBA) .on .Blood .Sugar . 
At 16 or 26 hrs after· the .intraperitoneal .administration o.f .4 .4 
nunoles of L-,DBA/kgbody weight (14) to fasted rats, the blood glucose 
levels of the .. treated rats were comparable to those :of the controls. 
Effect of.Amino .Acids and .Anunon:i,a .on Free Amino.Acids .ofBr.ain .and Am-
. monia of Brain and Blood 
A short time (15-:-30 minutes) after the intraperitoneal administra-:-
tion of.LD99 • 9 (28) doses of L.;.leucine and L-lysine hydrochloric;l.e/kg 
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bo9-y weight .to rats .or .22 • .5 .mmoles .of .ammonium .acetate/kg bcidy ·weight to 
chic~s,. the animals 'deyeloped .the ,.typical sympt6Ill$ .of ,toxicity described 
by Greenstein et al. (28). .: dy.spnQea, extreme prostration and in some 
cases coma. The .admin;i.stratiot1.of smaller doses of .ammonium acetate 
(7. 0 or 12. 0 mmo,les/kg .body ·.weight;) .to .chicks ·.resulted in rio ·such symp-
toms of toxicity. Giving homoarginine ,at a .dose .of .5·:mmoles/kg body 
weight to rats caused no noticeable .symptoms rof .. toxicity, but doses of 
10 mmoles/kg body weight.resu],.ted.in.hypersensitiv.ity.and death after 
15-20 hrs. 
None. of· the treatments· mentioned ,.above .changed. the concentrations 
of glutamate or 'aspartate · in rat or chick brain •... However~ brain gluta-
mine concentratfons. of these .animals were higher tha,;,. .thoi;e of controls 
(Table I), the increase being· comparable with the increase in free glu-,- . 
tamine of rat brain following .treatment with a,Ln99 •9 dose of.ammonium 
acetate (74)~ The ,blood.ammonia concentration of rats .increased after. 
treatment with the.above mentioned amino .acids, in.agreement with.the 
findings of Greenstein et al. (28). 
·Intraperitoneal .administration of 4 •. 4 mmoles .of .L-::,DBA/kg body 
weight resulted in hyperi:rr.itability , .. tren;iors ,.and .convulsions '.in 12-17 
hrs; followed by death in 3...._a days. ·. The effect of this. tr.eat:Iilent: on. 
major free amino acids~ brain .ammonia .. and blood.apunonia i,s shown in 
Tables I.and IL At 30 hrs .. after treatment .with .L-4DBA the brain gluta.,... 
mine. concentration was significantly h:i,gher that1, normal •. , .Shorter peri-
ods of treatment with L-,DBA .al.so resulted in higher .concentrations of 
brain.glutamine, but the·increases were smaller.than.those of 30 hr 
rats •. At ..30 hrs after,treatment with L-DBA, the ·ammonia .concentration 


















THE EFFECT OF AMINO ACIDS AND AMMONIA ON THE CONCENTRATION OF .FREE GLUTAMIC 
AGIB, ASPARTIC AGIB AND GLUTAMINE OF BRAIN AND AMMON.LA OF BRAIN AND BLOOD 
Duration Brain 
Compound Dose a of Glutamic Aspartic Glutamine Ammonia 
Treatment Acid Acid 
mmoles/kg hr JJmoles/g Tissueb 
body wt 
Water - 30 8.5±0.24 (3) 1. 9±0. 18 (3) 4.1±0.09 (3) 1.3±0.01 (10) 
L-DBA 4.4 30 9.4±0.29 (4) 2.()±0.09 (4) 9-4±0-45 l4) 1. 7±0.16 (4) 
L-DBA 4.4 25 10.0 (1) 1. 5 (1) 7.2 /(1) 
1-DBA 4.4 20 9.6 (2) 2.3 (2) 6.6 (2) 
L-DBA 4.4 30 9.9+0.78 (3) 1.9:!().ll (3) 5.3+0.43 (3) 
Water - 1 8.4:t().30 (3) 1. 8:!:().20 (3) 3.6:t().40 (3) L-Homoarginine 
·HCl 20 1/4 9.6 (2) 2.2 (2) 5.5 (2) 
L-Lysine·HCl 36 1/2 9.2+o.20 (3) 2.l+o.10 (3) 4.9±0.63 (3) 
L-Leucine 64 1/3 9.3- (2) 2.2- (2) 7.8 (2) 
Water 1/4 8.5 (1) 2.4 (1) 5.3 (1) 
Ammonium Acetate 22.5 1/4 7.3 (2) 1. 5 (2) 6.3 (2) 
Water 26 12.5 (2) 2.5 (2) 6.1 (2) 










6. 9- (2) 
~he compounds were dissolved in 2.0 ml water and intraperitoneal injection, and equal volume of water was used for con~ 
trol rat injection. 
bData are mean values followed by their standard errors.with number of.determinations shown in parentheses. 




THE EFFECT OF INTRAPERITONEAL TREATMENT WITH 1- AND D-DBA ON THE CONCENTRATION OF FREE AMINO ACIDS OF RAT BRAIN 
Duration 
Treatment Dose a of Toxicity Glu Asp Glu NH2 Gly Ala Thr Ser P Ser GABA Orn Ammonia Lys Arg Urea 
Treatment Asp NH2 DBA 
.l(moles/kg hr )).moles/g tissue 
body wt 
Control - 30 No 11.9 2.9 3.1 0.8 0.6 0.5 1.1 1.0 2.0 0.1 2.0 0.3 0.1 1.6 Com:,rol - . 30 No 11.3 2.7 4.1 0.8 0.7 0.5 1.3 1.1 2.1 o.o 2.1 0.3 0.1 1.1 
I,-;DBA 4,4 30 Yes 12.2 2.3 7.0 1.4 1.3 0.9 1.7 -0. 9 4.1 2.9 2.1 0.7 0.2 3.6 
1,-;DBA 4,4 30 Yes 12.2 2.2 10.4 1.1 0.9 0.8 · 1.6 0.7 2.8 3.4 3.0 0.7 0.2 3.2 
I,-;DBA 4,4 30 Yes 9,5 2.0 9.3 1.0 1.0 0.7 1.5 0.7 3,3 4,0 2.2 0.5 0.2 2.8 
I,-;DBA 6.6 30 Yes ll.6 1. 9 7,7 1.2 1.5 1.2 1.7 o.6 3.5 3,3 3,3 0.7 0.2 3,5 
I,-;DBA 6.6 30 Yes 9,7 2.1 13.3 1.1 1.8 1.3 2.2 0.4 3.0 4.2 1.8 0.6 0.1 2.6 
I,-;DBA 6.6 30 Yes 9.6 2.1 10.8 1.3 1.4 1.1 2.1 o.6 4.1 5.3 2.1 0.6 0.1 2.9 
1-DBA 6.6 60b Yes 6.2 1.4 7,9 0.7 0.9 o.6 2.1 0.4 2.9 4.6 1.5 0.5 0.1 1.8 
1-DBA 6.6 101b Yes 9.5 2.2 7,4 0.8 0.8 0.6 1.4 0.6 2.1 1.5 2.0 0.3 0.3 2.7 
1-DBA 6.6 13ob Yes 6.8 2.8 12.8 0.8 0.5 0.7 1.2 0.5 2.0 1.1 2.1 0.4 0.2 5.6 
1-DBA 4,4 30 No 13.5 2.6 3.1 0.7 0.6 0.5 1.2 1.1 3.5 1.1 2.1 0.4 0.2 2.4 
1-DBA 6.6 30 No ll.6 2.7 4.6 0.8 0.6 0.5 1.2 0.7 2.2 0.2 2.0 0.2 0.2 2.5 
D,-DBA 4.4 30 No ll.l 2.8 4.2 0.8 0.7 0.5 1.2 1.2 2.4 0.1 1.9 0.2 0.1 3,4 
D-DBA 6.6 30 No 11.8 2.5 3. 7 . 0.7 0.6 0.5 1.2 0.8 2.1 0.1 2.1 0.2 0.1 2.6 
D-DBA 13.2 30 No 13.5 3.0 4.0 0.8 0.6 0.5 1.2 0.6 2.4 0.2 1.8 0.2 0.2 2.2 
~he compounds were dissolved in 2.0 ml water and administrated by intraperitoneal injection, and equal volume of water was 
used for control rat injection. 
bThe animals were killed near death. w 
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rats. This same treatment .resulted .in .a .blood .ammoni.a.concentration 
higher than that in controls; but much lower·than those-observed a few 
minutes after treatment with .L-,homoa.rginine -hydrochlo:ri.de;. L..-.lysine·--hy-
drochloride or L.,-leucine. (Table .I)-~ . Blood ammonia concentrations .mea-
sured at 2, 6, 12 and 20 hrs after L-DBA treatment were not higher than 
the.average value.30 hrs.after .treatment. 
When the ·.in traperitonea.l dose' of .L-,DBA was .increased .to 6 ~ 6 mmoles/ 
kg body weight, the rats .showed typical .toxic .symptoms ·in 10.,,,12 'hrs and . 
died .in 3-5 days~ · Intraperitoneal .administration of A.;4-,13. 2 mmoles of 
D--DBA/kg body weight resulted in no toxic .symptoms .. or ·decrease 'in growth 
(about.20.:.30 g per week). 
The effect on the concent+.ations .of .free amino aci.ds {which were 
analyzed in the ·amino acid analy.ze:t) .. of r.at brain .are .shown ·in Table II. 
At ,30 hrs after -treatment·.of .rats with 4 .. 4 .mmo.les/kg .body .weight of 
L-,-D_BA, the concentrations ·.of glycine,. alanine,. ,threonine, .Y-,aminobutyric 
acid (GABA) ·and lysine in brain were higher than iri control rats along 
with gl utamirie and ammonia -increases comparable·_ to· those. _.shown · in Tabie 
I. The concentration of DBA · in brain was _3..,4 :µnioles/g;. Although the 
sum of serine and phosp~oserine :.was comparable .to -that .of controls, the . . 
concenti-ation of -serine was .inc:i;-eased while· that of ·.phosphoserine de.,-
crec;1.sed. ·Increasing· the dosage of· L-=DBA to. 6. 6 mmoles/kg · body weight 
resulted·in·.the same.cha.nges·of·amino acid concentrations tn·brairi 
(after 30 hrs), except· for higher concentrations of DBA·.arid 'GABA· (Table 
II)~ At death tqe same treatment gave c9ncentrations·of glycine, ala-
nine, ·threonine, •GABA, serine·and·ammonia .comparable to·that of·-•controls, 
while the glutamine concentration·remained high .and phosphoseririe was 
slightly lower than_ that :-of controls·· (Table II). 
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1.,...;DBA .at a dose of ·-4.:4 .nnnoles/kg .body weight :.or -.higher:was not· 
always _fatal.-·· The:.fatality .was .about .80% ,at :a .dose of-4 •. 4 .mmoles/kg 
body weight and;about 95% at',a-dose of 6,6 mmoles/kg-body:weight. Some 
treated rats survived without ._toxic .symptoms;. _few $urv:ived .after showing 
toxic symptoms. Rats receiving D-:DBA .at a .dose,.up to .l:L2 ·mmoles/kg 
body weight showed neither- toxic .symptoms .nor .. decrease .in .growth, rate 
(about 20-30 g per week);. ·The,concentrations .of .the-free-amino acids in 
brains of surviving rats .. treated with e:i,ther D- ·.or L.a,DBA;- were· compara-
ble · to those of controls. • Less .than_.Q.2 .µmoles/g .brain .tissue of D-DBA, 
and less than 1. 2 µmoles/g brain _ tissue of L~-DBk:wer.e·.observed in sur"."' _ 
viving animals (l'aqle II). 
The -administration of 3~22 o.r 6.-45 ,mmo.les .ofL-DBA/kg·body weight. 
to chicks_ resulti:d in no .symptoms:of ·;toxicity .and .no·:de:c:rease·in growth 
rate. The injection ,of .12;9·.mmoles .of 1-DBA/kg .bo.dy weight:to ·chicks 
did not cat1se the hyper.irritability~ .tremors and '.convulsions :ob:served in 
rats, but -it appeared .to .inhibit .gr~wth .and .resulted :in·:increa:sed 'levels 
of brain· gluta'Qline (Table I). 
Effect of -L..i.,DBA,o.n ·,the .Fr.ee ·.Basic:·.Amino .Acids~ .Na:f: :a:nd-·J{.f>.o.£ ·:tiv.er and 
·Brain 
After the intraperitoneaL.administration .of.: L-:DBA :to:·:rc:tts, ::the free 
basic amino acid concentration of:liver was higher.than·::tn·:no.rmal rats· 
(Table III). At·l:hr after treatment the.free basic amino·acid·level of 
liver was five times higher· than that of controls. The·.dffference be-
tween DBA-treated·and control i::ats decreased .with increasing time of 
treatment.· However, 30 hrs aft:er.L-,DBA treatment,. the liver still con-
tained a small amount'of DBA. Although all the differences .between the 








THE EFFECT OF L-DBA ON THE CONCENTRATION OF FREE 
BASIC AMINO ACIDS OF RAT LIVER AND BRAIN 
Duration Basic Amino Acidsb 
of 
Treatment Liver Brain 
hr µmoles/g Tissue 
30 6.6+ 0.35 (2) 3.5±0.63 
1 34.0±4.15 (3) 4.1±1.25 
2 23.6±0.40 (2) 
15 15.2 (1) 





alntraperitoneal injection of 4.4 mmoles/kg body weight of L-DBA or 
equal volumes of water to rats. 
bData are reported as mean values followed by their standard errors 
with the number of determinations shown in parenthesis. 
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livers can·not·definitely be .attributed-.to .th~ .accumulation"of DBA, 
paper- chromatography .of .the .desalted basic: amino· acids ·.from-rat livers 
demonstrated the presen~e .of larger amounts of DBk.than·lysirie ·or argin,-
ine. The Rf vah,ies of 1-1-DBA; lysine and .arginine .obtained by paper 
chromatography (see Experimental) were 0.29, 0.23 and 0.18, respectively. 
This accumulation of DBA by.liver .agrees .very .well.with r.esults·obtained 
by. other workers ( 41, 89). --
The concentration of-free basic amino .acids in brain~l hr after_ 
L-DBA treatment·· was only· slightly .different· from .that .of;.the -controls. 
However, 30 hrs af te.r L""-DBA treatment· the average ·.concentr.a tion · of free 
basic amino acids· in- brain was '.increased .from .4;:l to -5;7 .µmo·les/g (Table 
III) and paper, chromatography revealed .the .pr:esence of ·DBA; · Thus, . it 
appears that a slight amount·of ,an .intraperitoneal .dose·of·t-DBA does 
enter the brain and the·accumulation .increased with time;·· Slight pene-
tration of··L-'-DBA into· rodent·brain .has·.been·.p.reviously::reported py 
Kessel (12). 
The changes in concentrations of free basic .amino··acids:in brain 
was readily observed when the automatic .recording· amino·.acid :.analyzer 
was applied·to assay the .tissue extracts., Although DBA·coufd not be 
separated from ornithine·by·the short column.of the-analyzer; the con-
centration of ornithine in·control .rats;was very low (0.02-0;08·µmoles/ 
g) and was assumednot tochange·with DBA treatment. The·co:ncentrations 
of b:rain basic amino·acids;:including GABA and ammonia, measured at 0, 
1, 3, 9 and 15 hrs after·the onsetof_toxic .symptom$ .of r:ats treated 
intraperitoneally with 4;4 mmoles/kg body weight of 1--DBA, are shown.in 
Table IV.· The lowest concentration of L-'-DBA observed at the onset of 
tc;>xic symptoms. was 2. 25 µmoles/ g brain tissue, .re.aching:.a maximum. at 9 
0 
TABLE IV 
CHANGES IN CONCENTRATIONS OF BASIC AMINO ACIDS .OF L-DBA-
TREATED RAT BRAIN AFTER THE ONSET OF SYMPTOMS -
Durationb Basic Amino Acids 
Treatmenta after Orn 
Symptom GABA DBA Am Lys Hist 
hr µmoles/g Tissue 
Control c 2.0 0.1 2.0 0.3 0.1 
le Cc;mtro · 2.1 o.o 2.1 0.3 0.0 
L-DBA 0 3.7 2.6 2.2 0.3 0.1 
1...:DBA 0 3.3 3.1 2.6 0.4 0.1 
L-DBA 0 3.4 2.3 2.7 0.2 0.1 
L-DBA 1 3.4 3.1 2.9 0.3 0.1 
L-DBA 3 5.0 3.1 3.0 0.5 0.2 
L-DBA 3 4.8 3.4 1.8 0.5 0.1 
L-DBA 9 5.6 4.7 7 •. o 0.7 o. 2. 
L-DBA 9 4.9 3.2 2.5 0.9 0.2 
L-DBA 9 5,3 3.5 3.0 0.7 0.2 
L-DBAd 15 4.1 2.9 2.1 0.7 0.2 
L-DBAd 15 2.8 3.4 3.0 0.7 0.1 
L-DBAd 15 3.3 4.0 2.2 0.5 0.1 
a As mentioned in Table III. 
b The range of onset of symptoms.is 12-18 hrs. 

















dThe data are adopteq from 30 hr treatment with L-DBA in Table II. 
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hrs after the onset of toxic .symptoms. These results are in accord with 
the data•in Table III. The increase in concentrations of· GABA·and ly-
sine in rat brain was parallel to the increase of DBA. At 9 hrs after 
the onset of - toxic symptoms, GABA was increased to a maximum of 2 to 3 
times that of the controls, whereas the sum of lysine; .arginine and 
histidine was 3 times that of .the controls (Table IV) . 
. + + 
The concentrations of Na or K in brain or liver·measured at 1, 
15 or 30 hrs after intraperitoneal treatment with· L"'-DBA were not consis-
tently different enough from those found in the controls to indicate a 
definite effect due to L-DBA treatment. However, 1 and 15 hrs treatment 
with L-DBA lowered the concentration of K+ in liverslightly. 
Effect·· o.f · Intr.acerehraL.Treatment· .. of L..a.,~lutamine con·the ·eoncentrations 
of -Free· <:;lutamate, ·Aspartate ·and ·Glutamine·.of Rat Brain· 
The intracerebral -injection of 11. 5 mg ( 78 .8 µmoles) of L-glutamirte 
in.0.2 ml saline to rats had no·effect on either·the .concenttations of 
free glutamic acid and aspartic acid· (Figure 6}, which were~comparable 
to those·of controls; or on growth rate. The penetration of glutamine 
into brain tissue occurred within one minute, and reached a maximum 
after 30 minutes. After 100 minutes, brain glutamine concentration was 
decreased.to the level found in controls without changes·inconcentra-
tions of glutamic and aspartic acids. The,highest·concenttation of glu-· 
tamine observed was 9.12 and 9.24 µmoles/g at 30 and 50 minutes, re-
. spectively, which represented about 20% of the injected dose. There was 
no difference between saline and water used as solvents·for the gluta-
mine (Figure 6). 
The position of this·intracerebral·treatment·is between·cerebrum 





0 20 40 60 80 100 
Time (minutes) 
Figure 6. Effect of Intracerebral Treatment of L....Clutamine on 
the Concentrations of L-.-Oluta.mate, L-Aspartate and 
Glutamine of Rat Brain. 
The values reported are averages of 5 treated rats and of 3 con-
trol rats. 
Glutamate, • Control. 
----<DI--- Aspartate, • Control. 
Glutamine, Control. 
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saline to rats resulted in uncontrollable spasms and jumping immediately 
after injection, lasting approximately 10 minutes. The same effects 
were observed in intracerebral treatment of rats with 2 mg of ammonium 
acetate, recovery requiring about 30 minutes. The injection of water 
had no observable effect on the rats. 
Effect of Intracerebral. Treatment.·w.ith L'""DBA ·.and ·r>.:,DBA-.t.n··.Rats on the 
Concentrations ··of Brain ·Free -Amino Acids 
The rats were extremely prostrate immediately after·the intracereb-
ral treatment with L~DBA or D-DBA, but recovered after 30-40 minutes in 
the case of L-DBA. At 1~1~ hrs after intracerebral treatment with 7 mg 
of L-DBA, the rats showed the toxic ·symptoms previously obse·rved 30 hrs 
after intraperitoneal treatment of rats with 4.4 mmoles/kg·body weight 
of L-DBA; Administration intracerebrally of 6 mg of D-DBA resulted in 
the same toxic symptoms in 15-20 minutes. Death followed in·l-2 days. 
Tables V and VI show the effects of.intracerebraltreatment of rats 
with L- and D-DBA, respectively, on the brain free amino acids. As high 
as 3.34 µmoles/g of D-DBA was observed to penetrate·the brain within 5 
I 
minutes, whereas L-DBA took about 10 minutes to reach a concentration 
greater than 2 ·µmoles/g. 
There were no clear·relationships between the·toxic-symptoms and 
the changes in concentrations of brain free amino acids, except that 
glutamine concentration was lower than that of controls·when·the pene-
tration of DBA began, and phosphoserine concentration ·was ·dec·reased 50% 
when rats were neardeath. ·The·occurrence of:toxic·symptoms·did not 
coincide with the penetration of DBA into brain over 2 µmoles/gas was 
observed in. intraperitoneal ·· treatment. There was· a latent period of 
10-20 minutes for D'7DBA treatment and of 60-80 minutes for L.-DBA treat-
TABLE V 
THE EFFECT OF INTRA.CEREBRAL TREATMENT WITH L-DBA ON CONCENTRATIONS OF FR.EE AMINO ACID OF RAT BRAIN 
Duration Free Amino Acids 
Treatment a of Glu NH2 Orn 
Treatment Glu Asp Asp NH2 Gly Ala Thr Ser P Ser GABA DBA Am Arg Lys Urea 
hr )Jmoles/g Tissue 
Control 1/6 9.7 2.3 4.5 0.9 0.7 0.5 1.5 0.6 1.7 o.o 3.0 0.1 0.3 2. 7. 
Control 1/3 10.9 2.1 4.6 0.7 0.6 0.5 0.9 0.6 1.9 o.o 1.7 0.1 0.2 2.5 
L-DBA . 1/12 11.3 2.5 2.9 0.8. 0.7 0.5 1.0 0.7 1.8 0.3 2.7 0.1 0.2 1.9 
L-DBA 1/6 10.1 2.2 4.2 0.7 0.8 0.5 1.1 o.6 1.8 2.3 0.9 0.1 0.2 0.8 
L-DBA 1/2 9.0 2.7 4.4 0.7 o.6 0.5 0.9 0.5 1.9 2.8 0.9 0.1 0.2 1.1 
L-DBA 1/2 9.8 2.4 4.6 0.8 0.7 0.4 1.2 0.6 1.9 2.5 1.2 0.1 0.2 1.5 
L-DBA 11/2 10.6 1.8 3.4 0.8 0.7 o.6 1.1 0.8 3.4 3.5 3.4 0.1 0.4 1.8 
L-DBA 11/2 8.4 2.5 4,9 o. 6 0.4 0.5 1.1 0.7 2.6 2.8 1.0 0.1 0.3 1.9 
L-DBA 5 9.9 1.8 4.5 0.8 0.5 0.5 1.0 0.6 3.3 1.1 1.0 o.o 0.1 1.4 
L-DBA 5 11.6 2.5 3.5 0.9 0.8 o.6 1.1 0.7 2.7 1.2 1.9 0.1 0.3 1.9 
L-DBA 5 7.3 1.8 4.4 0.8 o.6 o.6 1.2 0.5 4.2 3.1 1.1 0.2 0.5 1.5 
L-DBA 17 8.2 1.9 4.8 0.9 0.5 0.7 1.1 0.3 2.8 2.6 1.2 0.1 0.7 0.8 
L-DBA 17 7,7 1.9 4.3 0.9 0.5 0.9 1.0 0.3 3,8 2.2 1.2 0.1 0,7 1.8 
L-DBA 27 9.9 1.8 6.1 1.1 0.9 0.6 1.3 0,3 3.9 2.3 1.5 0.1 0.6 1.9 
L-DBA 27 9.5 2.4 8.4 1.1 0.5 0.8 1.4 0.3 3.0 3.1 1.5 0.2 0.6 2.9 
L-DBA 20(days) 11.9 2.3. 5.6 1.1 0.6 0.6 1.2 0.9 1.8 o.o 1.5 0.1 0.2 1.8 





THE EFFECT OF INTRACEREBRAL TREATMENT WITH D-DBA ON CONCENTRATIONS OF FREE AMINO ACID OF RAT BRAIN 
Duration Free Amino Acids 
Treatmenta · of Glu NH2 Orn 
Treatment Glu Asp Asp NH2 Gly Ala Thr Ser P Ser GABA DBA Am Arg Lys Urea 
hr .,umoles/g Tissue 
Control 1/6 9,7 2.3 4,5 0.9 0.7 0.5 1.5 0.6 1. 7 o.o 3,0 0.1 0.3 2.7 
Control 1/3 10.9 2.1 4.6 0.7 0.6 0.5 1.0 0.6 1.9 o.o 1.7 0.1 0.2 2.5 
D-DBA 1/12 10.4 2.2 2.8 0.7 0,7 0.4 0.9 0.7 2.0 3,3 3.0 0.1 0.1 1.8 
D-DBA 1/12 9,7 2.6 2.9 0.7 0.6 0,5 0.8 0.7 2.0 3,0 3.1 0.1 0.2 1.7 
D-DBA . 1/6 10.0 2.6 3.5 0.7 0.8 0.5 1.0 0.8 2.0 2.0 7,7 0.1 0.2 2.0 
D-DBA 1/6 9,7 2.4 .3. 8 0.7 1.3 0.5 1.0 0.6 2.4 2.1 2.7 0.1 0.3 1.4 
D-DBA 1/3 8.3 2.5 4,7 0.7 1.2 0.5 1.0 0.7 2.5 2.2 3,1 0.1 0.2 2.3 
D-DBA 1/3 8.6 1.7 3,7 0.6 1.0 0.4 1.0 0.5 1.4 1.3 3.8 0.1 0.2 1.0 
D-DBA 1/2 7,6 1.5 3,0 0.5 0.7 0.4 0.8 0.6 1.8 1.5 1. 7 0.1 0.1 2.0 
D-DBA 1/2 8.4 1.7 4.0 0.6 0.8 0.4 1.0 0.5 1.8 2.2 1.6 0.1 0.2 1.6 
D-DBA 11/2 9.0 1.3 9,4 0.9 1.1 0.5 1.2 0.7 2.8 2.4 1.6 0.1 · 0.3 1.6 
D-DBA 11/2 9,3 5,5 4.0 0.9 1.0 0.6 1.4 0.4 2.7 3,6 2.5 0.1 0.5 1.5 
D-DBA 5 11.7 2.3 4.0 0.9 0.8 0.6 1.2 0.6 2.1 1.3 1.9 0.1 0.3 2.8 D-DBA 5 11.0 2.7 6.2 0.8 0.6 0.8 1.2 0.6 4.1 3.2 1.1 0.3 0.9 1.8 
D-DBA 17 7,8 1.8 5.0 0.6 0.7 0.5 1.0 0.4 1.1 0,9 1.2 0.1 0.2 1.2 D-DBA 17 8.2 2.0 6.1 0.8 0.6 0.5 1.0 0.2 1.6 1.4 1.2 0.1 0.2 2.8 
D-DBA 27 9.6 2.1 5.1 0.9 0.8 0.6 1.2 0,3 1.5 0.7 1.2 0.1 0.2 1.3 D-DBA 28 10.3 2.3 5.2 0.7 0.6 0.5 LO 0.2 1.5 0.6 1.4 0.1 0.2 2.1 
D-DBA 20 (days) 7,7 1. 9 4,6 o.6 0.3 0.3 0.8 0.3 1. 7 0.1 1.1 0.1 0.2 1.8 
aA dose of 6 mg of D-DBA dissolved in 0.2 ml water, pH 7.0 or equal volume of water was given to rat between cerebrum and 
cerebellum. · ~ 
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ment .for. development of typical toxicity symptoms. 
Throughout the intracerebral studies, the concentrations· of brain 
free glycine, alanine, threonine, serine.and glutamic·acid were compara-
ble.to those of controls. Aspartate concentration was·very irregular, 
and, in most cases, slightly lower than in controls. ·Near d·eath, in 
both treatments, brain glutamine reached higher concentra·tton than in 
controls (Tables V and VI). However, the increment is lower than that 
of intraperitoneal treatment (30 hrs) with higher doses of L":".'DBA (Table 
I). An increase in GABA was observed after the intracerebral treatment 
with L...,DBA, but not with D-,DBA (Tables V and VI). 
Effect of L-Thyroxine Treatment-on DBA .Toxicity ·in Rats 
Thyrox;ine treatment·protected rats against the toxicity of L-DBA 
when treated intraperitoneally with a dose of less than-7~7 mmoles/kg 
body weight of L~DBA. The same thyroxine~treatment had·.no··p·rotective 
effect when rats were .given L- or D--DBA .i.ntracerebrally. The thyroxine-
protected rats. (L-DBA givenintraperitoneally) had normal concentrations 
of,blood ammonia and brain glutamine (Table I). 
Detoxification by · Orni thine ~.and -Aspartic Acid 
The intraperitoneal ·· administration of 10-20 mmoles/kg··body weight 
of ornithine alone, or with 4 mmoles of aspartic acid,· resulted in a de-
crease in the fatality from 80% (L-DBA alone) to 50% (with ornithine 
alone, or with aspartate before·treatment with L-DBA, based·on 53 rats 
examined). However, in some cases, the toxicity was··enhanced (rats 
died after 40 hrs instead of·3-,8 days). 
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Effect· of··L-DBA on Urea S:xnthesis oLLiver Slices 
The intraperitoneal injection of 4~4 mmoles of L-DBA/kg body weight 
to rats 30 hrs prior to the preparation of liver slices resulted in sig-
nificantinhibitionof ammonia·utilization and urea production (Table 
VII). In another series of experiments the addition of either 14.02 or 
6.46 mM L-DBA to the incubation media significantly inhibited the utili-
zation of ammonia and ureaproduction·by normal rat liver slices (Table 
VII), while the presence of 4. 22 mM L-homoarginine hydrochloride in the 
incubation media had no effect, 
Effect ofL--DBA onTissue.Urea and Urine Excretion 
Analysis of the urea·· synthesized by the liver slic-es revealed that 
liver tissue of L-DBA-treated rats contained con.siderably niore urea 
than that of controls~ Urea determination of tissue extracts obtained 
from L-DBA-treated and control·rats showed that the above observation 
was correct.and that blood·and·brain tissue of L-DBA-treated rats also 
had higher levels of urea than corresponding tissues of control rats 
(Table VIII). After treatment with·4.4 mmoles of L-DBA/kg·body weight, 
rats excreted up to 5 times as much urine than control rats.over a 30 
hr period during which no water was provided for either group. Thus, 
diuresis probably caue;ed the elevation in tissue urea concentrations. 
Histopathologic Examination·of·Liver, Kidney·and·Brain20Hrs.After 
L-DBA Treatment 
This-examination revealed changes in the brain tissue of.one of the. 
three L-DBA-treated animals examined. This tissue showed ce·llular loss 











INHIBITION OF AMMONIA UTILIZATION AND UREA 
FORMATION BY RAT LIVER SLICES WITH L-DBA 
No. of Amount 
Rats of Annnoniaa 
Treatment Used L-DBA Used 
nnnoles/kg 
body wt. µmoles/g wet 
Control 9 17.2 (20) 
L-DBA 9 4.4 11.2 (20) 
Control 4 (mM) 19.4 (8) L-DBA 14-:-o 8.4 (8) 








1. 7 (6) 
5.0 (4) 
1. 7 (4) 
data are reported as mean values with the number of determina-
tions shown in parentheses. The P values of variance were less than 
0.10. 
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appeared similar to· those· produced ·.by some neurotoxins or by relatively 
acute anoxia, No lesions were·observed in any of the· other tissues ex-
~ined. Therefore, the neurotoxic effect of L.-DBA might be the result 
of:gross strµctural damage to brain,. and not to liver and kidney. 
Noncompetitive· Inhibition·.of :Ornithine: Transcarbamylase •by L-DBA 
The effect of L-aspartate, ~- and D-DBA, thyroxine·an·d·ATP in vitro 
. on the activity of ornithine · transcarbamylase of rat liver is shown in. 
Figure 7 and Table IX~ . · The activity of ornithine .transcarbamylase was 
inhibited by L-DBA, whereas L-,aspartate, ATP., thyroxine: and ·D-DBA had no 
effect or caused a very slight: 'activation. The activity-i:rra reaction 
mixture containing 10 · ~- o.f · orni thine ·was ·inhibited · appraxi"lnately 40% by 
20 mM of L-DBA, The inhibition could·be reduced to·22% and ·14% in the. 
presence of 20 mM of D...;.DBA· and 1.5 ·mM of ATP, respectively~ L..:...aspartate 
and thyroxine had no effect·.on this ·i~ibition, When L;...DBA in;the reac.,-
tion mixture was increased·.to·40·mM, neither. D-DM, L-aspartate, _ATP nor 
thyroxine had any effect (Table IX).· 10 or 15 -~· of ·L-homoarginine in 
a reaction mixture containing 7, 5 mM of orni thine gave no·· appreciabie 
·inhibition. 
Figure 8 shows Lineweaver.;.Burk. plots of the activity·of ornithine 
· trimscarbamylase as a. function· of ornithin.e co.ncentration-in · the presence 
·of three concentrations of·L-DBA. Increased L-DBA conc~ntration·result-
ed in an increased slope; with· a ·common point of· intersection· on the . 
abscissa. From the three·points·of·intersections on the·ordinat:e, the 
values of KI obtained were 22.9, 23.2 and 23.2 mM,. respectively, with 
anaverage·KI of 23 •. 1 ~at pH 8 •. 3, 37°. The K and·V ·1ue·3 .• 3 mM and 
~ m .· max -




·. TABLE VIII 
THE EFFECT OF L-DBA ON THE CONCENTRATION OF 
UREA OF LfVER, BRAIN AND BLOOD 
Liver 
7.2 (1) 









aAs mentioned in Table III. 

















THE EFFECT. OF L-ASPARTATE, D-DBA, THYROXINE AND ATP ON THE 
ACTIVITY OF ORNITHINE TRANSCARBAMYLASE INHIBITED BY L-DBA 
COlllJ20Unds.Added 
D-DBA .L-Asp ATP Thyroxine Rate a 
































a Rate of citrulline formation. The incubation media com~isted of 
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Figure 7. Effect of L.-Aspartate. D-DBA. L-DBA. Thyroxine and 
ATP on the Activity of Ornithine-Transcarbamylase •. 
Incubation media ·c:onsisted-of·20 µmoles of'L:;..Ornithine in 2 ml. 
0.6 
-K I o - 10.,serr: 30 
[I] (mM) 
-200 0- 200 400·, 600 
1/[s] 0!)-1 
Figure 8~ Double Reciprocal Plots df the Inhibition of Ornithine 
'Iranscarl;,amylase. from Rat Liver by· L-DBA. ·. 
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value of 1.4 mM of rat liver omithine transcarbamylase for ornithine 
at pH 7.3-7.4 had been reported by Reichard (121). These·Lineweaver"'." 
Burk plots suggest that·L-DBA acts·as a classical noncompetitive inhibi-
tor for ornithine, although L,-DBA acts as a competitive inhibitor for 
ornithine in the studies of·Herrmann et al. (82) with·purified ornithine 
transcarbamylase obtained· from.NeurosporaCrassa.· 
Discussion 
The physiological effects of L- and D,-DBA were comp·ared· with those 
of other amino acids and, in·thecase of .L-DBA, found·to differ in 
several ways. The dose of L-DBAnecessaryto produce·toxic effects was· 
considerably lower than·that·of the other amino acids·examined, and of 
the toxic levels of ammoniaand·other amino .acids reported·byGre-enstein 
~ al. (28). The symptoms of toxicity after treatment with L--DBA were 
different and occurred much more slowly than those·resultingfrom lethal 
doses of ammonia. Lethal doses of other amino acids and ammonia re"'." 
suited in dyspnoea, extreme prostration and in some cases coma, as de-
scribed by Greenstein et·aL .(28).,. and in a high .blood'ammonia level 
shortly after administratfon.(Table I), ·whereas L~DBA resulted·in hyper ... 
irritability, tremors and convulsions- starting 12-15 hrs after·treatment 
· and in slight. increases :f,n the brain and blood ammonia levels (Table I) . 
. These observations suggest that the mechanism of.toxicity for L-DBA 
differs from that for certain other amino acids and ammonia; and that 
the catabolic rate might.be the key point accounting for this difference. 
Although the other amino acids or ammonia resulted in an acute 
ammonia.toxicity, the slight increase in ammonia concentration in blood 
of L--DBA.:..treated rats suggested either no ammonia toxicity (from L-DBA) 
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or a. chronic toxicity. The acute toxicity of the other amino· ·acids is 
believed to result· from a· rapid. release of ammonia· from.· the· large dose. 
of the amino acid, thus exceeding the capacity of liver urea synthesis 
to detoxify ammonia. This·results in an.accumulation of large excesses 
ammonia in blood and other tissues (26, 28). 
Liver is known. as the maj.or·· site .of urea synthesis •. · L-DBA has been 
demonstrated to inhibit the ammonia utilization and·urea productio-q. both 
·invivo·and in vitro and·to inhibit the ornithine transcarbamylase, 
which may account for· the slight ·-increase in blood ammonia·· concentration 
and in the marked increase.· in brain glutamine concentration;· The obser.;. 
vations that D-DBA has no effe.ct on ornithine transcarb.amylas:e ·in vitro 
and D-DBA-treated (intraperitoneally) rats have normal brain_glutamine 
and no toxic symptoms suggest that the inhibition of ornithine trans-
carbamylase may account for·the slight increase in blood.ammonia· concen-
tration, thus resulting in·the·marked increase in brain·glutamine con-
centration. Moreover, the observation thata uricotelic animal, the 
chick, was not susceptable -· to .acute· ammonia toxicity up · to -a dose of 
12.0 nnnoles/kg body weight. of annnon::l..um acetate, but L-DBA caused .. thta in-
hibition of growth in the chick suggested· that chronic.· ammonia· .toxicity 
~Y not be the cause of death of·L.-DBA-treated rats. 
The marked increase in brain·glutamine con.centtationin·rats given 
t.:.DBA intraperitoneally indicates that the brains of these animals are. 
detoxifying appreciable amounts of ammonia (26). The -high concentration 
of glutamine in rat brain·probably does not cause toxicsymptoms, be-
cause the intracerebral treatment with glutamine resulted in an accumu-
lation of,glutamine in rat brain (Figure 5) without toxic effects.· 
Although it·was observed that D-DBA had no effect on the ornithine 
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·transcarbamylase of rat· liver while L-DBA acted .as a noncompI~·titive in-
hibitor, the intracerebral treatments with small doses (6-7 mg) of L-
and o-;.oBA resulted in.rapid (see Results) developme~t of the same toxic 
symptoms observed after intraperitoneal treatment. However;no toxicity 
was observed after intraperitoneal treatment ·with D .... DBA- at a ·dose up to 
3 times.thatof L-isomer~ These observations suggest·that·the primary 
mechanism: of toxicity of L-·and D-DBA may not. be inhibition of.the rate 
of liver urea synthesis by these·compounds but rather·their·presence in 
brain (Table II). 
Rather large doses of homoarginine were required for toxi·city. The 
toxic symp~oms and effect on the concentrations of blood ammonia and 
brain glutamine were si~ilar·to·those. resulting from·lethal doses.of 
other amino acids or ammonia~ Therefore, even though significant quan-
tities of hc:,moarginine have been fou,nd· in seeds ·.of L. sativ.as, ··L~ ·c:icera 
· or L~ clymenum, the species associated with neurolathyrism in man, 
·horses and cattle· (5), the findings in this study indicate that it is . . . 
not a_primary lathyrogenic·factor·in these plant~, but has·toxicity 
characteristics similar to ·.other amino acids (26). 
The report (122) that thyro:x:ine treatment decreases the ·pen·etration 
of DBA into rat brain and·protects aga.inst the neu:i:oto:,,cicity that it 
causes suggests that: the entry of .DBA into. brain is. necessary for some 
of,itsneurotoxicit:y. In this studywe observed that thyroxine treat-
ment protected against L-DBA toxicity only.when L-DM was given intra-
peritoneally in a dose, less than, 7. 7 nunoles/kg body weight~ 'l'hyroxine · 
failed to prevent·L-DBA (given intracerebrally) toxicity; even when the 
dos_e of L-D.BA was. as low as 6 mg. Moreover, .after intraperitoneal 
treatment with 4.-4 mmoles/kg body weight of !,+DB.A. the thyroxine,-protected 
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rats had normal concentrations of brain glutamine and blood ammonia, and 
thyroxine had no effect on the activity of ornithinetranscarblamylase 
from rat liver in vito or in .Y!Y£,, and on the activities, L- or D-DBA 
as a substrate of L-amino acid. oxidase from Crotalus ··· adamanteus venom 
and D"7"amino acid oxidase from hog kidney in vitro. These observations 
suggest that the prevention; by thyroxine, of the toxicity of L-DBA may 
not·be related to the deaminationor transaminations processes, ·although 
Vivanco. et al. (122) have suggested that· the protective effect of thy-
roxine on the toxicity may be through ap. influence on the deamination or 
transamination processes·which render these substances non--toxic. 
Liver was known. ~12, 41, 89) and shown in. this study (Table III) to 
accumulate DBA. The rapid transfer of this amino acid was explained on 
steric grounds. The two amino groups of. DBA can chelate with metal 
(27-29) to form a stable six membered ring and form, at the same time, 
a stable Schiff base with pyridoxal (27). This complex. can be arranged 
in a stable chair cop.formation and the carboxylic · gr.oup ·in both the D-
and. L-isomer is on an equatorial bond so that DBA is greatly stablized. 
L-:DBA D-DBA 
The nontoxic effect of D-DBA (given intraperitoneally) may be due to the 
rapid excretion by kidney, resulting ina limited chance for absorption 
by brain. Although L-DBA inhibits ornithine transcarbamylase noncom-
petitively for ornithine, while D.-DBA has no effect, it·is not known to 
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date whether this is a factor i:n .t~e .nontox_ic effect ·of· D.-ItBA (given 
.intraperitoneally). 
•'. 
The studies of the concentrations of free amino acids of brain in.;.. 
d.icate that the t_oxic symptoms of intraperitoneal DBA-treated r,ats "are 
· related to the penetration .of DBA ·.into brain .and the ·.modification of. 
;.,;!,~·,.1:)fainfree>·amino·:acid.s·'. (':fables It. and r:v ~ VI). The :tncrease in 
glutamine accounts for the detoxification of ammonia b}" brain; however, 
whether changes in.concentration of some other.brain free amino·acids is 
related. to toxicity is not known. 
t.oxici ty of DBA · is not·· an· ion-,exchange pr.obl~m, .. because.·.the ·· symptoms 
right -after treatment with·DBA and ·.saline .were:.diff.erent· (see Results) • 
. The observations that· there ·was a similar latent period··.'for··the appear~ 
ence of.the symptoms of.·toxicity after an.acc1,1I11ulat:ion:of··2;;0 µmoles of 
DBA in brain, which was .a minimaL..amount .observed ·.to .. be r¢qutre-d for the 
toxic symptoms, and·that·DBAreacted with .oxalacetc:!,te··nonenzymically at 
an appreciable rate• (see .Results ·.in Chapter V) suggest·· that "the .. ca-rbonyl 
trapping ability of DBA may· be .responsible for a part:·:of · the neu.rotoxic ... · 
ity. 'rhiosemicarbazide, · a carbonyl trapping agent, has been··reported 
as a convulsant (88). 
Also .observed in this.· study the :fact that nQnenzymic· and/or enzymic 
,··· - . . .. 
reactions. might exist in the rat brain duting storage in the·· deep freez;.., 
( 0 0 er ~20 to -30 ). The changes in concentration of free amino·acids of 
rat brain during storage are shoWl\. in Tables X and XL The decrease 
in glutamine plus glutamate·is approximat:ely equal to: the·increase in 
GABA.· Loss of-glutamine accounts for much of the ammonia increment. 
The increase in aspartate is presumed, but not proven,, to be, due . to 
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TABLE X 
CHANGES IN CONCENTRATION (µmoles/g tissue) OF FREE AMINO 
ACIDS OF RAT BRAIN DURING STORAGE IN THE DEEP FREEZE 
Amino Acid or Compound 
Glutamic Acid 
Aspartic Acid 









10.4±0.5 (9. 7-10.9) 
2.3±0.1 (2.1-2.4) 
4.1±0.7 (3.0--4.5) 
0.6±0.1 (O. 6 ""0. 7) 
1. 9±0. 2 (1.7-2.3) 
0.3±0.2 (O .1 ...... 0. 4) 
1. 0±0.1 (0. 9 -1. 2) 
2.3±0.5 (1. 7 -3.0) 
16 Weeks 
. c tissue. 
8.7±1.4 (7.1-10.6) 
5.3±0.7 (4.4 ...... 5,9) 
1.8±1.1 (0.3 -2.8) 
1. 9±0. 4 (1. 5 -2. 4) 
5. 9±0. 54 (5. 5 """6. 7) 
1.9±0.1 (1.8 ..... 2.1) 
0.6±0.0 co.5 ...... o.6) 
7 .8±1. 8 (5. 5 ....... 9. 4) 
bPhosphoethanolamine + Glycerophosphoethanolamine 
cData are mean values followed by their standard .. errors with the 
range shown in parentheses. 
TABLE XI 
CHANGES IN FREE AMINO ACIDS OF RAT BRAIN DURING STORAGE IN 
THE DEEP FREEZE, EXPRESSED AS PER CENT OF O TIME CONTROLS 
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Amino Acid or Compound 4 Weeks 8 Weeks 12 Weeks 16 Weeks 
Glutamic Acid 91 86 80 83 
Aspartic Acid 121 152 190 231 
Glutamine a 68 46 42 45 
Alanine 235 255 215 323 
a-Aminobutyric Acid 230 232 255 305 
Ethanolamine 359 437 431 583 
Ethanolamine Ester1;1 b 76 59 58 57 
Ammonia 239 268 242 342 
a Includes Asparagine 
bGlycerophosphoethanolamine + Phosphoethanolamine. 
hydrolysis of acetylaspartate while the ethanolamine increment is only 
in part accounted for by adeciease in ethanolamine esters. These re-
sults indicate that during the storage period enzymic ornonenzymic 





Preparation of L..a.Amino Acid Oxidase from·Rat Kidney. 
The method of Blanchard et .al. (123) was modified to prepare the 
L-amino acid oxidase·from rat.kidney. Because of ,inadequate· amounts of 
tissue, the enzyme was isolated and purified only through the first 
sodium sulfate precipitate step and dialyzed. 
Step 1 
The tissue was passed through·a Harvard press and homogenized in a 
Waring blender for 20 seconds, three times, with 10 volumes of acetone 
cooled to -10° to -15° wit;h dry ice. The temperat1;1re was maintained in 
0 0 the range (-:'10 to -15 ). After homogenization, the suspension was 
rapidly filtered under suction. The procedure was repeated twice using 
the residue of the filt;ration for rehomogenization. After the final 
filtration, the filter cake was pulverized to facilitate drying in the 
air. The dry, light brown.colored powder was stor~d in a freezer when 
not in use. 
Step 2 
The acetone powder was extracted with 20 volumes of water, and the 
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suspension was.stirred for 30 minutes. The insoluble particles were re-
moved by centrifugation at 600 xg for 10 minutes. Anhydrous sodium sub· 
fate was added (15 g per 100 ml .of supernatant) to the supernatant in 5 
portions over 20 minutes with constant stirring. Acetic acid, 0.5 !, 
was then added to bring the pH to 5.1. The adjustment of pH should be 
earried out electrometrically with a glass electrode. The protein pre-
cipitate was collected by centrifugation at 10,000 xg for 10 minutes 
and resuspended in water to a concentration of 1.5 ml/g acetone powder. 
All the procedures in this step were performed at room temperature. 
Step 3 
The above enzyme·solution was dialyzed overnight at o0 against 
0.025 M phosphate buffer; pH 7.3 (5·ml enzyme .per liter buffer), with 
several changes of buffer~ The dialyzed enzyme solution was then used 
for assays. 
Assay. of L--amino Acid · Oxidase ···from Snake·· Venom and Rat. Kidney 
The rate of oxidation was measured with a Yellow Springs Model 53 
polarographic oxygen electrode; which is a Clark type, membrane-coated 
electrode, by following the change in % of saturation~ Calibration of 
an oxygen electrode apparatus can be accomplished in a number of ways 
(124). For example, since the solubility of oxygeo, in. water is known, 
an approximate calibration can be achieved by setting the meter at 100% 
0 . with air saturated H20 (23.87 µ!/ml at 37) and assuming a linear meter 
response in all other situations (i.e., buffer solutions). 
The incubation media ·consis.ted · of substrate· (amino acids), 16 .6 mM; 
Tris-HC! buffer (for the.pH range of 7.0 to 9.0), or glycine-NaOH buffer 
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(for the pH range of 9.0-10.0),. 0.2 mM; catalase, 2-4 µg; and crude 
enzyme, O. 2 ml (1. 3 g rat kidney), or pure enzyme (sna~e venom), O. 03-
0~05 mg (as reconnnended by Worthington Co. (125)) in a total volume of 
3.0 ml. In the case of snake venom L-amino acid oxidase, 40 mM of KCl 
were added. The mixture was preincubated in a 37° water bath for 10 
minutes, and the reaction was started by adding the enzyme. The oxygen 
0 consumption at 37 was measured with the Yellow Springs Model 53 oxygen 
electrode. Readings were taken at 3minute intervals until the satura-
tion was decreased to nearly 10% or, for the slow reactions, during the 
period (30-40 minutes) when the oxygen utilization is constant (Figure 
9). The rate of oxidation was measured by the slope of the initial re-
action (Figure 9), which was multipled by 2 because catalase regenerated 
0.5 moles of oxygen from one mole of H2o2 formed, and was expressed as 
µmoles of amino acid oxidized or µl o2 consumed per hr per mg of pro-
tein. When crude enzyme was used, results were expressed per ml enzyme 
preparation. The substrate concentration used for assay was in the 
first order region of the velocity vs. substrate curves (e.g. 0.4 K ), 
m 
However, the range of enzyme concentration used is linear with rate con-
stant k' (Figures 10 and 11). 
The protein concentration of crystalline L-amino acid oxidase of 
snake venom was determined with the Cary 14 spectrophotometer by 
measuring the absorbance at 275 mµ, A275 x 0.56 = mg/ml (125). 
Assay of D-Amino Acid Oxidase from Hog Kidney 
Conditions for this assay were the same as for the assay of L-amino 
acid oxidase with a modification in the incubation media. The mixture 
consists of substrate, 33.3 mM; enzyme, 0.1-0.2 mg; and pyrophosphate 
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Figure 9. The Oxygen was Measured with the Yellow Springs Model 
53 Oxygen Electrode. 
Incubation media consisted of L-DBA, 16.6 mM; Tris or glycine 
buffer, 0.2 mM; KCl, 40 mM; and L-amino acid oxidase from snake 
venom, 0.005 mg/ml. Assayed at 37°. 
2.81 
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Figure 10. The "lnA vs t" Plot of the Assay of L-DBA with L-
Amino Acid Oxidase from Snake· Venom. 
A is remaining concentration of L-DBA at ·time t. The rate con-
stant k' is calculated from slope. 0.0147 mg/ml enzyme was 
used for assay. 
0 0.01 0.02 
[E] (mg/ml) 
Figure 11. The "k' vs [E]" Plot of the Assay of.L-DBA with L-
Amino Acid O:ddase from Snake Venom. 
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buffer (pH from 7.5 to 9.0),. 13.3 .mM. The concentrations of substrate 
and enzyme used for assay were chosen in the same manner as those for 
the assay of L-amino acid oxidase (Figures 12 and 13). The -protein con-
centration was determined spectrophotometrically by measuring the ab-
sorbance at 280 mµ • . A280 x 0.625 = mg/ml (126). 
Identification of the Products . of the Enzymic Reaction 
The mixture, as described previously, was incubated in a 37° water 
bath for one hr, with or without catalase, gassed with a small stream of 
oxygen or exposed to air. The ·reaction was tenninated ·byadding an 
equal volume of 6 N HCl. The precipitate was removed by centrifugation. 
The reaction products were then identified by paper chromatography. Due 
to the difficulty in isolating small .amounts of keto acid ·products, they 
were prepared as 2,4-dinitrophenylhydrazine derivatives ·and examined by 
infrared spectroscopy as described in Chapter II, or treated with H2o2 
or sodium borohydride prior to identification by paper chromatography. 
Results 
Effect of pH on the Activity ·of Respective Amino Acid Oxidases with L-
and D-DBA 
With crystalline L-amino acid oxidase from Crotalus adamanteus 
venom and D- amino acid oxidase from hog kidney, the optimum pH obtained 
for L-DBA and D-DBA are 8.6-9.2 and 9.2-9.4, respectively (Figure 14). 
In the case of L-amino acid oxidase, the enzyme was inactivated after 
10 minutes at a pH above 9.4. 
The potency of enzymic activity of partially purified and dialyzed 
L-amino acid oxidase from rat kidney (12 µl 02/hr/g wet tissue for 
~ 
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Figure 12. The· lllnA vs t'' Plot of the Assay of D-DBA with D-
Amino Acid Ox:idase from Hog Kidney. 
A is temaining concentration of L_-DBA at. time t. The rate con-
stant k' is calculated frotrt. slope •. 0.0277 mg/ml enzyme was 





Figure 13. The.Ilk' vs [E]" Plot of the Assay of D-DBA with 
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pH 
Figure 14. The pH-Curves of L- and D-DBA with Respective 
Amino Acid Oxidases. 
The enzymic activity was detennined with a.polarographic 
oxygen electrode, YSI Model 53 • .A indicates 50 µmoles 
of L-DBA with 0.015 mg of L-amino and oxidase from Crota-
lus adamanteus venom, in 0.2 M Tris and glycine buffer, 
and eindicates 85.7 µmoles of D-DBA with 0.083 mg of 




L-leucine) towards L-DBA was too low to measure accurately. The same 
problem has been observed by Park and Kim (127). Although the optimum 
pH obtained was 7.3-7.8 for L~DBA with L-amino acid oxidase from rat 
kidney (about 1.3 g of kidney was used for each assay), the activity 
observed was only slightly greater than the controls, from which only 
L-DBA was omitted. The net activity (3 pl 0/hr at pH 7.4) may be ex-
perimental error, since amino acid .analysis showed the presence of amino 
acids in the dialyzed rat kidney enzyme preparation. 
Kinetics of L- and D-Amino Acid Oxidases with L- and D-DBA 
With crystalline enzyme, the double reciprocal plots (the Line-
weaver-Burk plots) of the activities of amino acid oxidases as a func-
tion of DBA concentrations are shown in Figures 15 and 16. The Michealis 
constant of D-amino acid oxidase from hog kidney for D".'."DBA is 35.7 mM; 
2 0 the V is 2.75 x 10 µmoles/hr/mg protein at pH 9.2, 37 (Figure 15). max 
The L-amino acid oxidase from Crotalus adamanteus venom has a same Km 
(40 mM at pH 9.0, 37° for L-DBA) and .a ten times higher V . (2.26 x 103 max 
µmoles/hr/mg protein, Figure 16). Thus, per mg of the enzymes studied, 
the L-isomer of DBA can be oxidized faster than D-isomer. 
The 0.15 mg of D-amino acid oxidase used for each enzymic assay. 
are equivalent to approximately 4.5 g of hog kidney (Massey et al. 126). 
Effect of Thyroxine on the Oxidative Deamination of.L-, and D-DBA 
The presence of 0.01-2.0 µg of L-thyroxine at pH 9.0 in the incu-
bation media had no effect on the enzymic activities of both D-amino 
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Figure.15. Double Reciprocal Plot of the Activity of D-Amino 
. Acid O:x;idase from Hog Kidney as a Fmiction of. 
D-DBA Concentration. 
Rate was measured at pH 9.2, 37°, and 0.15 mg of .enzyme. 
0 0.1 
-1 1/[sJ (mM) ·· 
0.2 ,, 
Figure16. Double Reciprocal Plot of the'.Activity of.L-Amino 
Acid Oxidase.from Crotalus adamanteus Venom as 
a Function of L-DBA Concentration. 
Rate·was measured at pH 9.0, 37°, and 0.0442 mg enzyme. 
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The·· intraperitoneal administration .of 200 µg_ L:-,thyroxine (pH. 9;0) to 
rats daily for eight days before .the.preparation .of L-amino aoidoxidase 
.of ~idney, resulted in, .no. observable .effect on the oxidase a.ctiyity 
toward L- and D-DBA. 
The· Oxidative Deamination .Pro.ducts .of L-, .and D-DBA 
Instead of the Y-amino group .of ... l;)oth isomers of DBA, the a-amino 
group W'as,oxidized to give .the .a ... keto amino acid in reactions·catalysed 
by either D- or L..;.amino acid .oxidase._ In ,the presence of catalase (2-3 
µg), a-keto-Y-aminobutyric acid_ . (KABA) .was formed;. -13-alanine was formed 
instead of KABA when catalase ·was .absent •... This .keto ,amino acid can be 
isolated as. its 2,4-dinitrophenylhydrazone d,er.ivative. The infrared 
spectra of.both.the keto acid and.its derivative are the same as those 
of synthetic. compounds (Figures 3 and 4) •. KA.BA .and f3-,alanine were iden-, 
tified by paper chromatography in several solvent systems (Table XII). 
' . . . . 
KABA can be reduced by sodium.borohydride .to .give.a-,hy.droxy'.""'Y-aminobuty..-
ric acid (HABA), ·which was also identifiecl .by .. paper ·chromatography 
(Table XII). The identification .of KA.BA, .HABA and .13-,.alanine· was en-
hanced. by the availability·of synthetic .or .commercial(f3-,alanine) au-
· then tic compounds~ KABA gives a yellow color with .n;Lnhydrtn; -JIABA, a 
purple color and s-,1anine 1 .a blue .color. 
The enzymic reactions of L-,DBA with .L-amino acid .oxidas.e from snake 
venom, including the chemical .reactions, are shown in Figure 17~ The 
reactions of. D-:-DBA with D-amino acid oxidase follow the .same pa·ttem. 
Paper chromatography failed·to identify the products·from·the reac-
tion of L-DBA with rat kidney L-amino acid oxidase_and the amino acid 
analyzer revealed that the hydrogen peroxide treated reactio~mixture 
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TABLE ~II 
IDENTIFICATION OF KABAa, HABAb AND a-ALANINE BY PAPER CHROMATOGRAPHY 
Rf 
KABA Yellow Blue Purple 
Solvent Spot a-ala Spot HABA Spot 
EtOH:H20 (76:24 .23 . 23 .37 • 36 .25 .25 
tBuOH:HOAc:H20 (4:1:2) .18 .18 • 39 .38 
MeOH:H20:Pyridine 
(20: 5: 1) .36 • 36 .36 • 36 .35 . 35 
Pyridine:H2o (65:35) • 30 .30 .28 .28 .20 .19 
aKABA = a-Keto-Y-Aminobutyric Acid. 
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did not· contain detectable amounts (0 •. 002 .µmoles/ml) of a-alanine, gly-
cine or aspartic acid. However, it ,cannot be concluded that kidney is 
not able to oxi<;lize L-DBA •. · .It: may be that t:he enzymic· activ:tty is very 
low and the amount.of enzyme used was not s1,1,fficient to give a detect-
able reaction. 
Discussion 
The L- and D-isomers of DBA can be rapidly oxidized by the respec-
tive crystalline L-:- and D-amino acid oxidases from snake venom and hog 
kidney. They are better substrates than L-leucine for L-amino acid oxi-
dase and D-alanine for D-amino acid oxidase, respectively (Table XIII). 
However, L-amino acid ox:l.dase f~om .rat .kidney showed a .great .preference 
for L-leucine compared to L-DBA. Although .the. L-amino acid.oxidase·pre-
pared from rat kidney had activity of l~ .. µl Oilhr/g .wet .tissue for L.-
leucine (9 µl o2/hr/g wet tissue by Blanchard!!_ al, .123)., ·1...:.nBA was 
o:x;idized at a rate of 3 µl o2/hr/g wet: tissue, which may be experimental 
error. No oxidation product of L-DBA with rat kidney L-,amino aGid oxi-
dase. was detected either by paper chromatography or with the amino acid 
analyzer, while KABA was identified as the oxidat:ion product .of both 
isomers of DBA with the crystalline enzymes. 
L-amino acid oxidase, where it occurs in a m8Il)maliantissue, is 
very weakly active (128); rat kidney and liver being the only satisfac-
tory s.ources of this enzyme (59). On the other hand,. it is present to a 
surprisingly high level,in the venoms of a number of species of snakes 
(129). Therefore, the failure· to observe L-DBA oxidation with rat kid-
ney. oxidase was not surprising •. Blanchard et.!.!.· (123) reported that 










D-alanine a 4.2 
I},,,DBA 16.6 
TABLE XIII 
COMPARISON OFENZYMICOXIDATION RATES BETWEEN L- AND 
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Park and Kim (127) 
Our Results 
Greenstein et al. (128) 
Our Results 
athe rate·is_an approximate value which is calculated (divided by 6.25) from µmoles/hr/mg N 




and 0.01 units per 100 g .tissue .in three .ammonium.sulfate·frE:ictiotiations, 
and the yield in the preparation .was only 1.4%. -•· .The oxidation of L-DBA 
is difficult to examine unless .an appreciable·amoUilt of purified, enzyme 
is·a.vatl;able. 
Although the content of-D-,amino acid .oxidase.inrat .kidney and 
liver· was not known, hog kidney. has 4.8 .unit;s .per .g .tissue in·'the homo-
genate, and from 30 g of kidney·Mass~y ~ .al. (126) obtained 1 mg of 
crystalline enzyme with a specific activit;y of 12.5 units/mg.·.protein. 
The study with · this enzyme · (s •. a. 2 .15, from .Worthington Co~} and L..-
amino acid oxidase from.Crotalus .adamanteus venom (s.a. 2.3,· from Worth-
ington Co.) herein reported, showed that.V .for .t-,DBAwas 10 times · max .. · · · 
higher than that for D-DBA, with approximately .the sam~ .Km: values. The 
obs~rvation that KABA, · the oxidation· product -.of both '.L- .and· D--DBA, was 
decarboxylated to give .f3-alanine .when .catalase .was .absent·.or inadequate 
is in agreement with the findings ·o~ .Koeppe ·.and Mushahwar (41). 
.... CHAPTER V 
. ·, .TRANSAMINATION 
.Experimental 
Animals 
As described in Chapter III, the .fed .rats .were:used .for experiments. 
Tissue Preparations 
The method of Rowsell (130) .was used for the preparation of tissue 
homogenates. After decapit;ation~ rat liver and kidney.wer.e··:removed and· 
chilled in ice. The·tissues were passed througha·Harvard press and· 
homogenized in an ice-cold Potter-ElvenhJem.homogenizer·withcold.0.1 M 
phosphate buffer, pH 7~4, and filtered through surgical ,cotton gauze~ 
Homogenates were. diluted· with· buffer·· to eight .. times . the ,volume· of the 
tissu~ and· centrifuged· at· 10;000 xg for 10 .minutes .• · .The-..10 ,ooo: xg pel-
let was· resuspended in .buffer such· that 5 .inJ,. .. of the :so,l.utfc;,n--was· equiva-. 
lent.to 1 g of "tissue; This·was·called .the '.mitochondrial fraction. 
Nine voluil).es of. the mitochond,rial fraction _and a portion of the o:riginal 
homogenate were treated with one volume ·of 2% Triton X-100 •.. All frac-
tions,, (homogenate, mitochondria .and 10,.000 xg supernatant;), .with or 
with.out Triton X-100,were dialyzed against buffer at room .temperature. 
fqr 20 h,rs-, with. several--ch;mges of buffer. The dialyzed c,:ude: trans-




This m~thoci was used only.with .a .transamination :system in which one 
of the substrates was oxalacetate · (131).. The decrease :in concentration · 
of oxalacetate was measured with··a Cary .14 .spectrophotometer by following 
the. change in absorbance .at 280 niµ at 25°. In pri.nciple· t;he method re"'" 
quires that the ot:her components do not. have. an interfering .absorption 
at the wavelength used for a given .component. Oxalacetate has a very. 
high millimolar extinction .coefficient at 280 .mµ,. · 0. 53 · in·· 0.05 M phos-. -,-
phate·buffer, pH 7.4 (131) .and<0~47 .. in O~l M .phosphate buffer, pH 7.4. 
. .. -
All other possible components have comparatively l9w extinction cc;,effi.,... 
cients, among them, KABA is ·the highest at 0.040. 
The enzymic assay mixture consisted.of NaHl04'-,K2ij.P04 buffer, 87.5 
mM (O~l·M., pH 7.4); amino acid, 20 -~; oxa:J,.aceta,te, 2 mM;·pyridoxal-5-
. phosphate, 10 µg; the enzyme· prepar'a,tion, 2511.;. and .water.:·.to :make· a total 
volume of 1. ml. A reference ·.cuvette .. consisted .of .tl;,,e .same reagents ex-
eluding oxalacetat:e. The .nonenzymic .assay .mixture··was varied by the 
desired experimental conditio~; · in which the buffEj!.r· was changed or 
·omitted, and in somecases metal ions we+e added. This rate·was meas-
ured by following the changes in the absorb~nce at 260 mµ; Oxalacetate. 
has a .. shoulder.near .. 260 mµ .in· the spectrum. The assay .is :much more' 
sensitive at 260 mµ than at 280 .mµ·. However, the millimolar--'.extinction 
cc;,efficient · (0. 962 in aqueous· solution, pH 7 .0) at .260· mµ mus·t· .. be .care-
ful.ly checked, occasionally, during a series .of :-assays. 
Qualitative Filter·. Paper-- ~hromatography 
·The final products of·transamination are of ii;iterest·eyeri .. w:l.thout· 
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quantitativeconsiderations. The method of Rowsell (130}wasapplied 
with modification. To a 15 ml Corex centrifuge tube were added.40 
µmoles of sodium pyruvate, a.-:ketoglutarate, or oxalacetate,·4o µmoles 
of amino acid, and 20 J:,ig of pyridoxal-5-,phosphate (total volume, l ml). 
0 After the preincubation in a 37 water bath for 5 minutes, one milliter 
of dialyzed crude enzyme was added and the tube was immediately gassed 
with N2 and sealed with a rubber stopper. The contents of the tubes 
were mixed and incubated at 37°. At timed intervals, 0.1 ml of the con-
tents.were removed and.added immediately to 0.1 ml of 2 N HCl to dena-
turethe protein, which was removed by centrifugation~ The reaction 
tube was regassed with N2 and sealed for further incubation. A 10 to 
25 µ!.aliquot of each sample was spotted on phosphate buffered filter 
· paper (132) and developed· in several·· solvent systems by the ascending 
· technique~ Authentic amino acids were included .on each chromatogram. 
·After development, the papers.were dried in a hood at room temperature. 
Then they were sprayed with 0~2% ninhydrin in 95% ethanol; dried and 
heated at· 110° for 30 seconds. 
· The nopenzymic. reactions ~re performed in,sim:tlar. fashion, the· co-, 
factor, enzyme and buffer being omitted. At the termination of incuba-' 
tion, the mixture was brought to pH 2.2 with 6 N HCl, refrigerated, and 
assayed by paper chromatography and with an amino acid analyzer. 
Sodium· Borohydride· Reduction·and .Amino AcidDerivatives 
The reaction mixtures mentioned above.were also treated with excess 
sodium· borohydride at pH 7;0·while stirring at room temperature for 4 
hrs. Aport:f.on of the reducedproducts were acidified·topH 2.2-and 
analyzed with an amino acid analyzer. Their N-acetylethylesters or 
83 
N-trifluoroacetyl _£-butyl esters, whose preparations are described in 
Chapter II, were analyzed with .GLC .on QV-,1 or SE-30 column, using a tern-
0 . . - 0 0 
perature. program of 2 /min from 100 to. 250 . The modified Barber Cole-, 
man Model 5000 with a hydrogen flame detector was used. Some of the GLC 
peaks were assayed in.the mass spectrometer. 
Results 
Nonenzymic· Transamination·· Between·L-DBA and .Oxalacetate 
There should.exist other·nonenzymic transaminations withL-:-DBAbe--
sides that with oxalacetate~ ·However, oxalacetatewas the only keto 
acid acceptor which was· easily· assayed spectrophotometrically. 
The evidence for nonenzymic transamination between L..;DBAand o:x:ala-
cetateis shown in Figure18. The'reaction was not affected-by the 
presence of crude transaminases.· The reaction rate was not significant.,-
ly affected by pyridoxal-5--phosphate, but<did increase.when-phosphate 
buffer was absent (Figure 18), 
Some. Possible Nonenzymic··Transaminations 
For meaningful · measurements of. enzymic. ·. transamina tion ·rate, the 
possible nonenzymic transaminations involved in·.an· enzymic assay must 
be considered. Figure 19 · shows these possible transaminations ~ ·· No non-
enzymic·transaminations were·detecte<;i between oxalacetate .and glutamate 
or .. a-alanine, or· between. a'-'ketoglutarate and aspartate~ · Thus, they 
should not interfere with·the enzymicassay. 
There were nonenzymic ·· transamina tions between· L-DBk-and .oxalacetate. 
or pyruvate; and between D-PBA and oxalacetate. (Figure· 19). · · The milli-
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Pyridoxa:J.-5-phosphate 
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Figure 18~ Nonenzymic Transamination Between L~DBA and Oxalace-
tate. 
The incubation med:,la consisted of L-DBA, 20 mM; oxalacetate, 0.8· 
mM; and pyridoxal-5-phosphate, 20 µg/mL Assayed at pH 7, 4 and 
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Figure 19~ Some Possible Norienzymic:·rransaminatio~s .:r:nvolveci in 
Enzymic Assays. · 
The incubation media con~isted of amino acids, 20 mM; keto acids 
(except oxalacet~te, 1. 6 .mM), 2.0 mM; and O .1 M phosphate. buffer, 
pH 7.4, to make up a volume of 1 ml. Assayed-at 23°, and followed 
with the Cary 14 at 280 mµ. 
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and 0.0215, respectively, .in .phosphate buffer, pH 7;A, at 280 mµ. There-
fore, a small rate of nonenzymic· transamination between ·L.,DBA and pyru.,-
vate.or oi-ketoglutarate would not'be detected under·ourconditions of 
assay.· 
The• Optimum~ pH of.·Nonenzymic··.Transamination 
The nonenzymic transamination .was pH.-,depertdent, at least in the 
case of L-DBA and oxa.lacetate; · The ·.optimum pH for L.;.;.DBA and oxalacetate. 
is 6.0-8.0 (Figure 20). • The reaction rates were express.ed· in terms of 
µmoles/min by- the equation: · 
as derived by C_ohen (131), where --dD/dt is the change' in absorbance, and 
k is the millimolar extinction coefficient, in which ·it· is assumed that: 
k +k -k .. --k .. +k OAA · ·· DBA prod......., ;OAA -'DBA 
where k0AA = 0.47 and ~BA= 0.0013 as measured at 280 mµ. 
··Effect of Buffers on the Nonenzymic ·Transaniiination .Between.La..,DBA and 
Oxalacetate 
Table XIV shows the effect of phosphate buffer, pH 7.4, and Eb'TA 
buffer, pH 7.4, on the nonenzymic transamination·between L..,DBA and oxa.-
!acetate. The reaction was strongly inhibited by phosphate· buffer. An· 
amount-of 100 mM phosphate·buffer, pH 7.4, gave an inhibition· of up to 
72%. $urprisingly, EDTA·had no effect on·the reaction. Pyridoxal-5-






















1.0 2.0 3.0 4.0 5.0 
pH 
6.0 7 .0 s:o 9.0 10.0 
Figure 20. Optimum .pH of Nonenzymic Transamination Between L-DBA · 
and Oxalacetate in Aqueous Solution. 
TABLE XIV 
EFFECT OF BUFFERS ON THE NONENZYMIC TRANS-
AMINATION OF L-DBA WITH OXALACETATE 
Phosphate Buffer EDTA Buffer a Rate CdD) pH 7. 4 pH 7 .4 dt 




10.0 . 073 
2.5 0049 
2.5 10.0 .038 
27.5 72. 5 .022 
40.0 60.0 .022 
80.0 20.0 .020 
100.0 .020 
\ 
90.0 , 019 
(20 µg pyridoxal) 
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a Measured at 280mµ. Media consisted of L-DBA, 20 mM and oxalace-
tate, 2 mM, pH 7.4. 
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Effect of Metals on the Nonenzymic Transamination Between·ta;,DBAand Oxa-
lacetate 
Within a range of 7.5-,,300 .µ~ of CuSO 4 , of 4..,.150 .µM of BaC12 , and of 
2-10 .µM of Feso4 examined, there.was no significanteffecton the rate 
of transamination between 1,..,DBA andoxalacetate with or without 10 mM 
of EDTA, pH 7. O, whereas 36 µM of ·FeSO gave approximately 20% inhibi-- 4 
tion. No assay could be made with EDTA in the presence of· FeSO 4, be-
cause.the addition of EDTA caused a slow decrease in absorbance. 
The Nonenzymic Transamination Between ·.L""DBA:~and Oxalacetate·.in. the Pre-
sence. of ··crude· Trarisaminases, ··coenzyme · and Glutamate 
Pyridoxal-5--phosphate had a small depressive effect(about·10%) on 
the rate of-nonenzymic·transamination between L,.-,DBAand:oxalacetate. 
The addition of.crude transaminases from the liver 10,000 xgpellet: 
treated with 0.2% Triton X-100 or liver 10,000 xg supernatant had no 
effect. 
The reaction rate of enzymic transaminationbetween glutamate and 
oxa:).acetate with the crude transaminases .was slight:ly lower··:±n the pre-
sence of I.-DBA (Table XV);, ·The depression was up to 30% with·a liver 
10,000xg supernatant or kidney 10;000 xgpellet t:t'eatedwith 0.2% Tri-
ton X-100. This could be due to L-DBA competing with glutamate.for 
either the enzyme or oxalaceta te, probably the lat tel;'. · 
Enzymic· Transamination_···.of····L"'-DBA ·by ·Homogenates of·Rat Liv:er·.and· Kidney 
Paper chromatography revealed that the reactions with the crude 
enzymes from.liver and kidney were essentially the same,·except the liver 
homogenate worked better. The oxalacetate was the best keto acid accep-
TABLE xv· 
THEENZYMIC TRANSAM:INATLON.OFGLUTAMA'I'E WITH OXALACETATE IN"THE PRESENCE OF L-DBA 
;,-'.;, . . • . 
Glu + OAA E · :;: a.KG+ Asp E Glu + OAA ~~a.KG+ Asp+ ??? · 
_pyr-5-phosphate (l) pyr-5-phosppate. 
(2) 
Tissue .. (L-DBA present) 
Fractionations· 
-dD -d[oAA] -dD) -dD) -dD -dD -d[OAAl 
dt dt- dt 1 dt: 2 dt) 2- Tt\ dt · et 
A280 /min µmoles/ A280/min µmoles/min/g 
min/g 
Liver Homogenate 0.14 110. 0.03 0.16 0.13 103 
Homogenate + 0. 2% 
Triton xlOO 0.16 140 0.03 0.15 0.12 101 
10,000 xg Supernatant 0,09 66 0.04 0.10 0.06 46 
10,000 xg Pellet+ 
0.2% Triton xlOO 0.21 94 0.04 0. 22 · 0.18 · 82 
Kidney Homogenate 0.05 38 0.03 0.06 0.03 30 
c 
Homogenate+ 0.2% 
Triton xlOO 0.14 124 0.03 0.13 0.10 88 
10,000 xg Supernatant 0.04 32 0.03 0.07 0.04 28 
10, 000 xg Pellet + 
0.2% Triton ~100 0.11 49 0.03 0.11 0.08 34 















tor, visible results being.seen by paper chromatography after 1 hr incu-
bation, whereas with pyruvate or a-ketoglutarate the a-alanine or glu-
tamic acid formed, respectively; were observed only after a 3 hr incuba--
tion period. In spite of the _fact that the transamination was fastest 
between L-DBA and oxalacetate, a-,alanine was formed instead of asparate. 
Paper chromatography showed·that qualitatively the major products after 
20 hrs incubation were the same· as those after 1 hr incubation. The 
longer incubation gave much higher product concentrations. The mixture 
remained clear during the 20 hr incubation; no microbial growth was ob-
served. At 20 hrs after incubation of L-DBA with oxalacetate or pyru-
vate in.the presence of liver enzyme, a yellow spot developed (Rf= 0.22 
in 76% ethanol), which gave 6-alanine in the presence of hydrogen per-
oxide, and was identified as KABA. The analysis of this20hrs incuba-
tion solution in the amino acid analyzer revealed that there were more 
than 20 amino acids detected (Figure 21), among them ct-alanine was the 
major component followed by glycine; Two compounds showed very high in-
tensity at 440 mµ. Most of.the compounds were acidic~ 
Product· of ·Nonenzymic · Transamina tion ··Between L-DBA and· Oxalaceta te 
When L-DBA and oxalacetate were mixedtogether·at--pH 6.0, bubbles 
were formed immediately. Nitrogen. gas slowed down the bubbling, but did 
not stop it. Apparently, there was adecarboxylation during transamina-
tion. 
At 20 hrs after the incubation of L-DBA with oxalacetate in the 
presence of.nitrogen.gas, _the pH of the solution was 7.2. · The solution 
was decolorized during reduction with sodium borohydride. Paper chroma-
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·Figure 21. · 'Amino AcidAnalyses ·of ·the Traasamination Products of L.:.DBA and Oxalacetate in the Pre-





without reduction; Too many ninhydrin-,positive components were present. 
Assay of the reaction·mixture (w:j..thout NaBH4) in the amino acid analyzer 
revealed that at least 7 amino acids were formed duringthe nonenzymic 
transamination (Figure 22). F.ive·of them were veryacidic, having re-
tention times between 20 and60 minutes; the other two appeared at 122 
and 134 minutes, respectively. · Apparently; none. of these -- seven com-
pounds was one of the common amino acids. 
Analysis of the reduced-solution showed·6 major·peaks·along with 
- -·• several verf imall:peaks.- -- Tnl major peaks- had retention times between 
aspartic :~cid1·arid: glutaminet{Figur£%: 23) ·• 
GLC of N-acetyl ethyl esters and N:--trifluoroacetyl n-butylesters 
of the nonenzymic transaminationmixture reduced with sodiumborohydride 
0 0 are shown in. Figure 24. With temperature programming from 100 to 240 , 
the_N-acetyl ethyl esters·gave·S major peaks on.OV--1·(8 ft, 1% column, 
whereas N-trifluoroacetyl n-buty esters gave 4 major peaks·on SE-30 (10 
ft, 1%) column. These showed the .presence of many products produced by 
simply mixing L-DBA with oxalacetate at pH 6. o~ · Unfortunately, scanning 
in the mass spectrometer showed·that none of the peaks was apure_amino 
acid derivative, and almost every peak consisted of·at·least 2 compounds. 
Identification via thin-layer chromatography is unsuccessful to date. 
Discussion 
Although the identification·of the productsof.nonenzymic transa.,.. 
mination ofL-DBA with oxalacetate was unsuccessful, evidence·for the 
reaction are the spectrophotometric assay (Figures 18 and 19), ·the amino 
acid analyses (Figures 22·and23) and the GLC of the N-acetyl ethyl 
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(Figure.24). This nonenzymic transamination is not a .simple.reaction, 
because.it gives at least 7 major ninhydrin .... positive compounds. Most of 
them are very .acidic; 
Copper and Barium ions had .no catalytic effect on thenonenzymic 
transamination while 36 µM of FeSO 4 exerted an inhibition.· Metal ions 
will chelate to both amino groups of DBA (29). The·lack metal ion cat-
alyses. at low concerttrations of copper and barium ions; indicate that 
the metal chelates are not more active in nonenzymic transaminations 
here reported. The cause of the inhibition by Feso4 at 36 µMis not 
known to date. 
The amino acid analyses revealed that most of the peaks observed 
after 20 hrs nonenzymic transamination of L"'-DBA with·oxalacetate (no 
NaBH4 added) were different· from those· observed when crude liver. or kid-
ney transaminases were present {Figures 21 and 22). The·rate of enzymic 
transamination was very·slow.· · It was surprising to find alanine as the 
major product· (glycine next) instead of aspartic acid, with oxalacetate 
as the keto acid acceptor(Figure 21); The following is a plausible 
explanation for the finding of;alanine as a major product, 
,--
1 IN. T. 
I" ,'f 
I.Amino Aicd.~ 
1 Products J 
\{Fig. 22) l 
1! .· ino Acid '/'' J 
Products 
~ig. 21) '2 
L-DBA + OxalaC;etate~E.T.. Aspartic-8-s.emialdehyde l . (plus KABA -co \.. j 
· 2 '\. Aspartate '¥ (alkaline) 









where E.T. is enzymic transamination, and N.T. nonenzymic transamina-
tion. The formation of glycine indicated aspartic-13-semialdehyde as one 
of the products of enzymic transamination of L-DBA with oxalacetate, 
because aspartic-13-semialdehyde is very unstable at neutral or alkaline 
pH. It will enolize and be oxidized to give a--aminomalonate, which is 
stable in alkaline solution but forms glycine by decarboxlyation in 
acid. 
The amino acid analyses also revealed two ninhydrin-positive com-
pounds with high, and approximately equal, intensity at 440mµ (Figure 
21). The finding in the enzymic transaminationmixture·ofKABA, by 
paper chromatography, and glycine, by amino acid analyses, suggested 
that the two 440 mµ peaks are KABA and aspartic-(3-semialdehyde~ KABA 
is rather stable under incubation conditions. followed by 1 !!_ HCl (stor-
age). However, aspartic--(3-semialdehyde forms glycine during similar 
treatment. Therefore, the sum of glycine·plus aspartic-(3-semialdehyde 
is a measure of gannna transaminationwhileKABA formati.on·represents 
alpha transamination. The results presented in Figure 21 indicate that 
most of the transamina.tion of L-DBA with oxalacetatewas gamma. 
From the observations and-discussions above concerning·the trans-
amination of L-DBA with oxalacetate the following is concluded:· ·a) the 
nonenzymic transamination was superior to the enzymic reaction, b) the 
major p.roduct of enzymic transamination of L---DBA with oxalacetate is 
aspartic-13-semialdehyde while·KABA is the exclusive product in the oxi-. 
dative deamination by amino acid oxidases, and'c) the main enzymicreac-
tion path to give L-alanine is not known.to date. 
Although the pattern·of increment in brain.alanine·and glycine con-
centrations·of intraperitoneal L---DBA-treated rats(Table II)· is similar 
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to that observed in the enzymic transaminatio.n of DBA with'-·oxalacetate 
(Figure 21), it is not known whether· a combination of nonenzymic and en-
zymic transamination of DBA accounts for these increments·(inbrain). 
The finding of, aspartic-S--semialdehyde as an ~nzymic · transamination · 
· ... . . 14 
product.of L-DBA agrees with the suggestion (41) that some·L-DBA--2- C 
is converted to aspartate-z .... 14c or to somt? closely related compoundo 
... CHAPTER VI 
SUMMARY 
KABA has been synthesized by.condensing diethyl.oxalate with a-ala-
nine ethyl ester in the presence of EtO- Na+ followed by refluxing with 
cone. HCl for 2 hrs. KABA was characterized by NMR and IR spectra. 
KABA is the.oxidation product.with L- and D-DBA incubated snake 
venom L-amino acid oxidaseand hog. kidney.D-amino acid .oxidase; respec-
tively, in the, presence of. catalase. When catalase was. absent, the pro-
duct was 13-alanine. The study with crystalline hog kidney D-am:ino acid 
oxidase and.Crotalus adamanteti,s venom L-amino·acid oxidase herein re-
ported, showed that Vmax .for L.,.,DBA was 10 times .. higher than . that for D-
DBA~ ·with approximately the ·same Km values. 
The study of rat kidney L-amino acid oxidase is uneuccessful to 
date. Unfortunately the enzymic actiyity. is .very low,.· if existent, and. 
the amount of enzyme used was .. not sufficient to give a detectable reac- .. 
t:ion •. 
The enzymic· t:ransamination of L_;DBA was very slow. .Alanine was 
found as the major product (glycine next) instead .of aspartic acid, with 
oxalacetate as the keto acid (acceptor). A plausible reaction scheme·is 
presented to explain the find,ing of alanine as a.major product. The· sum 
of glycine plus aspartic-13-semialdehyde is a measure of gamma transamin-




DBA can transaminate with oxalacetate nonenzymically with an opti-
mum pH between 6.0 and 8.0. With a reaction mixture·consisting of 20 mM 
of L-DBA and 2 mM of oxalacetate; an amount .of 100 mM of phosphate buf-
fer, pH 7.4, gave·an inhibition of up to72%. Metals-had no effect on 
the reaction, except 36 1,1M of Feso4 gave approximately 20% inhibition. 
At least 7 amino acidl;l were formed during the nonenzymic transamination. 
Apparently, none. of those 7 comp.01inds was one of the common-amino acids. 
The identification of.nonenzymic transamination pro·ducts is unsuccessful 
to. date. 
· L-DBA was found to inhibit ornithine transcarbamylase of ·rat liver 
noncompetitively while D-.DBA·had no effect. The intraperi:tonealadmin-
istration of toxic doses of L-.DBA to rats resulted inhyper±rritability, 
tremors and convulsions in 12-,20 hrs and increasedthe·concentration of 
annnonia of blood and brain-slightly, and the·concentrattons of brain 
glutamine and GABA 2-3 fold. Intraperitoneal doses of.D-DBA, 3 times 
as high, had no toxic effects; Intracerebr1;tl treatment··w:tth small -\ 
doses (6-7 mg) of D- and L-DBA resulted in the same toxic symptoms as 
those observed after intraperitoneal treatment·with L~DBA; No severe 
modification in brain free amino acid concentrations was observed in 
the intracerebral treated rats. Thus, the rieurotoxicity may be due to 
that Dl3A which penetrates.bra.in. 
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